NO135243B - - Google Patents
Download PDFInfo
- Publication number
- NO135243B NO135243B NO3005/70A NO300570A NO135243B NO 135243 B NO135243 B NO 135243B NO 3005/70 A NO3005/70 A NO 3005/70A NO 300570 A NO300570 A NO 300570A NO 135243 B NO135243 B NO 135243B
- Authority
- NO
- Norway
- Prior art keywords
- general formula
- styryl
- residue
- lower alkyl
- dimethylaminoethoxy
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 26
- -1 2-quinolyl Chemical group 0.000 claims description 24
- 125000000217 alkyl group Chemical group 0.000 claims description 20
- 239000002904 solvent Substances 0.000 claims description 12
- 239000007858 starting material Substances 0.000 claims description 12
- 150000002576 ketones Chemical class 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 11
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 10
- 239000000203 mixture Substances 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 9
- 150000001299 aldehydes Chemical class 0.000 claims description 8
- 150000003008 phosphonic acid esters Chemical class 0.000 claims description 7
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- 230000015572 biosynthetic process Effects 0.000 claims description 6
- 125000005843 halogen group Chemical group 0.000 claims description 6
- 229910052739 hydrogen Inorganic materials 0.000 claims description 6
- 239000001257 hydrogen Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 5
- ZMHZFJLJDOTWDW-UHFFFAOYSA-N n,n-dimethyl-2-[2-(2-pyridin-2-ylethenyl)phenoxy]ethanamine Chemical compound CN(C)CCOC1=CC=CC=C1C=CC1=CC=CC=N1 ZMHZFJLJDOTWDW-UHFFFAOYSA-N 0.000 claims description 5
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims description 4
- 150000007522 mineralic acids Chemical class 0.000 claims description 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 4
- 150000007524 organic acids Chemical class 0.000 claims description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- PVOAHINGSUIXLS-UHFFFAOYSA-N 1-Methylpiperazine Chemical group CN1CCNCC1 PVOAHINGSUIXLS-UHFFFAOYSA-N 0.000 claims description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 235000005985 organic acids Nutrition 0.000 claims description 3
- 125000004174 2-benzimidazolyl group Chemical group [H]N1C(*)=NC2=C([H])C([H])=C([H])C([H])=C12 0.000 claims description 2
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims description 2
- 125000003342 alkenyl group Chemical group 0.000 claims description 2
- 125000004183 alkoxy alkyl group Chemical group 0.000 claims description 2
- 125000003545 alkoxy group Chemical group 0.000 claims description 2
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 238000001640 fractional crystallisation Methods 0.000 claims description 2
- 125000002768 hydroxyalkyl group Chemical group 0.000 claims description 2
- 125000004307 pyrazin-2-yl group Chemical group [H]C1=C([H])N=C(*)C([H])=N1 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 claims 1
- VPIDXLJVGVBFOW-UHFFFAOYSA-N C=1C=[C-]PC=1 Chemical compound C=1C=[C-]PC=1 VPIDXLJVGVBFOW-UHFFFAOYSA-N 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 44
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 36
- 125000005504 styryl group Chemical group 0.000 description 32
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 27
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 26
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 26
- 239000003921 oil Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 238000002844 melting Methods 0.000 description 14
- 230000008018 melting Effects 0.000 description 14
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 13
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- 239000000243 solution Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 11
- 239000002585 base Substances 0.000 description 10
- 238000003756 stirring Methods 0.000 description 10
- 239000013078 crystal Substances 0.000 description 9
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 8
- WJYNWFSNRMEPMF-UHFFFAOYSA-N 2-[2-(diethoxyphosphorylmethyl)phenoxy]-N,N-dimethylethanamine Chemical compound CN(CCOC1=C(CP(OCC)(OCC)=O)C=CC=C1)C WJYNWFSNRMEPMF-UHFFFAOYSA-N 0.000 description 7
- TWMYSXRSVLFCGX-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxy]benzaldehyde Chemical compound CN(C)CCOC1=CC=CC=C1C=O TWMYSXRSVLFCGX-UHFFFAOYSA-N 0.000 description 7
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 7
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 6
- MVPPADPHJFYWMZ-UHFFFAOYSA-N chlorobenzene Chemical compound ClC1=CC=CC=C1 MVPPADPHJFYWMZ-UHFFFAOYSA-N 0.000 description 6
- 238000001704 evaporation Methods 0.000 description 6
- 230000008020 evaporation Effects 0.000 description 6
- DRTZAIDVOGUYSP-UHFFFAOYSA-N pyridin-1-ium;chloride;hydrochloride Chemical compound Cl.Cl.C1=CC=NC=C1 DRTZAIDVOGUYSP-UHFFFAOYSA-N 0.000 description 6
- AUQITUJCWBROPQ-UHFFFAOYSA-N 2-[2-[2-(2-chloroethoxy)phenyl]ethenyl]pyridine Chemical compound ClCCOC1=CC=CC=C1C=CC1=CC=CC=N1 AUQITUJCWBROPQ-UHFFFAOYSA-N 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 238000009835 boiling Methods 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 235000011121 sodium hydroxide Nutrition 0.000 description 5
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 5
- WQMAANNAZKNUDL-UHFFFAOYSA-N 2-dimethylaminoethyl chloride Chemical compound CN(C)CCCl WQMAANNAZKNUDL-UHFFFAOYSA-N 0.000 description 4
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- DTNXIWBODCJJEU-UHFFFAOYSA-N [2-(2-pyridin-2-ylethenyl)phenyl] acetate Chemical compound CC(=O)OC1=CC=CC=C1C=CC1=CC=CC=N1 DTNXIWBODCJJEU-UHFFFAOYSA-N 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000000202 analgesic effect Effects 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 4
- 150000004678 hydrides Chemical class 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- BDAWXSQJJCIFIK-UHFFFAOYSA-N potassium methoxide Chemical compound [K+].[O-]C BDAWXSQJJCIFIK-UHFFFAOYSA-N 0.000 description 4
- SMQUZDBALVYZAC-UHFFFAOYSA-N salicylaldehyde Chemical compound OC1=CC=CC=C1C=O SMQUZDBALVYZAC-UHFFFAOYSA-N 0.000 description 4
- 229910052938 sodium sulfate Inorganic materials 0.000 description 4
- 235000011152 sodium sulphate Nutrition 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 4
- BIAWAXVRXKIUQB-UHFFFAOYSA-N 2-(2-phenylethenyl)pyridine Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=N1 BIAWAXVRXKIUQB-UHFFFAOYSA-N 0.000 description 3
- NIFAUKBQIAURIM-UHFFFAOYSA-N 4-(chloromethyl)-3,5-dimethyl-1,2-oxazole Chemical compound CC1=NOC(C)=C1CCl NIFAUKBQIAURIM-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 239000012279 sodium borohydride Substances 0.000 description 3
- 229910000033 sodium borohydride Inorganic materials 0.000 description 3
- BDZBKCUKTQZUTL-UHFFFAOYSA-N triethyl phosphite Chemical compound CCOP(OCC)OCC BDZBKCUKTQZUTL-UHFFFAOYSA-N 0.000 description 3
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 2
- LLCYXGBLEDYIDN-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxy]-1-phenylethanone Chemical compound CN(C)CCOCC(=O)C1=CC=CC=C1 LLCYXGBLEDYIDN-UHFFFAOYSA-N 0.000 description 2
- BDQWNFGSQOXARB-UHFFFAOYSA-N 2-[3-(dimethylamino)propoxy]-1-phenylethanone Chemical compound CN(C)CCCOCC(=O)C1=CC=CC=C1 BDQWNFGSQOXARB-UHFFFAOYSA-N 0.000 description 2
- DSHCOEWHRLVOTF-UHFFFAOYSA-N 2-[3-(dimethylamino)propoxy]benzaldehyde Chemical compound CN(C)CCCOC1=CC=CC=C1C=O DSHCOEWHRLVOTF-UHFFFAOYSA-N 0.000 description 2
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 2
- JRHHJNMASOIRDS-UHFFFAOYSA-N 4-ethoxybenzaldehyde Chemical compound CCOC1=CC=C(C=O)C=C1 JRHHJNMASOIRDS-UHFFFAOYSA-N 0.000 description 2
- ZWBJJNWJUXXFNP-UHFFFAOYSA-N 5-(chloromethyl)-3-methyl-1,2-oxazole Chemical compound CC=1C=C(CCl)ON=1 ZWBJJNWJUXXFNP-UHFFFAOYSA-N 0.000 description 2
- VVJKKWFAADXIJK-UHFFFAOYSA-N Allylamine Chemical compound NCC=C VVJKKWFAADXIJK-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- GODIVLKZGYEGBZ-UHFFFAOYSA-N Cl.CN(C)CCOC1=CC=CC=C1C=CC1=CC=C(C=CC=C2)C2=N1 Chemical compound Cl.CN(C)CCOC1=CC=CC=C1C=CC1=CC=C(C=CC=C2)C2=N1 GODIVLKZGYEGBZ-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- 238000007014 Michaelis-Becker reaction Methods 0.000 description 2
- 241000699666 Mus <mouse, genus> Species 0.000 description 2
- 239000005662 Paraffin oil Substances 0.000 description 2
- BHHGXPLMPWCGHP-UHFFFAOYSA-N Phenethylamine Chemical compound NCCC1=CC=CC=C1 BHHGXPLMPWCGHP-UHFFFAOYSA-N 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 238000005804 alkylation reaction Methods 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- CAWHJQAVHZEVTJ-UHFFFAOYSA-N methylpyrazine Chemical compound CC1=CN=CC=N1 CAWHJQAVHZEVTJ-UHFFFAOYSA-N 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000012452 mother liquor Substances 0.000 description 2
- NQUAUTVQZJQLIZ-UHFFFAOYSA-N n,n-dimethyl-2-[2-(2-phenylethenyl)phenoxy]ethanamine;hydrochloride Chemical compound Cl.CN(C)CCOC1=CC=CC=C1C=CC1=CC=CC=C1 NQUAUTVQZJQLIZ-UHFFFAOYSA-N 0.000 description 2
- RCAVMXODXXMCER-UHFFFAOYSA-N n,n-dimethyl-2-[2-(2-pyridin-2-ylethenyl)phenoxy]ethanamine;hydrochloride Chemical compound Cl.CN(C)CCOC1=CC=CC=C1C=CC1=CC=CC=N1 RCAVMXODXXMCER-UHFFFAOYSA-N 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 150000003254 radicals Chemical class 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- FHADSKGDQLZUIT-UHFFFAOYSA-N stilbene hydrochloride Chemical compound Cl.C1(=CC=CC=C1)C=CC1=CC=CC=C1 FHADSKGDQLZUIT-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- HVLLSGMXQDNUAL-UHFFFAOYSA-N triphenyl phosphite Chemical compound C=1C=CC=CC=1OP(OC=1C=CC=CC=1)OC1=CC=CC=C1 HVLLSGMXQDNUAL-UHFFFAOYSA-N 0.000 description 2
- 230000007306 turnover Effects 0.000 description 2
- RPMGSMBPOIFFKN-UHFFFAOYSA-N 2,7-naphthyridine-4-carbaldehyde Chemical compound N1=CC=C2C(C=O)=CN=CC2=C1 RPMGSMBPOIFFKN-UHFFFAOYSA-N 0.000 description 1
- NXNDEWNGCMCWMA-UHFFFAOYSA-N 2-(2-quinolin-2-ylethenyl)phenol Chemical compound OC1=CC=CC=C1C=CC1=CC=C(C=CC=C2)C2=N1 NXNDEWNGCMCWMA-UHFFFAOYSA-N 0.000 description 1
- NJWIMFZLESWFIM-UHFFFAOYSA-N 2-(chloromethyl)pyridine Chemical compound ClCC1=CC=CC=N1 NJWIMFZLESWFIM-UHFFFAOYSA-N 0.000 description 1
- IGHVSFVDNSDRCK-UHFFFAOYSA-N 2-(diethoxyphosphorylmethyl)quinoline Chemical compound C1=CC=CC2=NC(CP(=O)(OCC)OCC)=CC=C21 IGHVSFVDNSDRCK-UHFFFAOYSA-N 0.000 description 1
- UCDVGYTWCYDSRU-VOTSOKGWSA-N 2-[(e)-2-phenylethenyl]pyrazine Chemical compound C=1C=CC=CC=1/C=C/C1=CN=CC=N1 UCDVGYTWCYDSRU-VOTSOKGWSA-N 0.000 description 1
- SLNFFKAUEGIFPB-UHFFFAOYSA-N 2-[2-(diethylamino)ethoxy]benzaldehyde Chemical compound CCN(CC)CCOC1=CC=CC=C1C=O SLNFFKAUEGIFPB-UHFFFAOYSA-N 0.000 description 1
- SFLLGCQYLKKZQS-UHFFFAOYSA-N 2-[2-(dimethylamino)ethoxy]-4-methoxybenzaldehyde Chemical compound COC1=CC=C(C=O)C(OCCN(C)C)=C1 SFLLGCQYLKKZQS-UHFFFAOYSA-N 0.000 description 1
- FWWANUZXQIGOOI-UHFFFAOYSA-N 2-[2-[2-(2-chloroethoxy)phenyl]ethenyl]quinoline Chemical compound ClCCOC1=CC=CC=C1C=CC1=CC=C(C=CC=C2)C2=N1 FWWANUZXQIGOOI-UHFFFAOYSA-N 0.000 description 1
- GYXWNSDLDXGMGU-UHFFFAOYSA-N 2-chloro-n,n-dimethylpropan-1-amine Chemical compound CC(Cl)CN(C)C GYXWNSDLDXGMGU-UHFFFAOYSA-N 0.000 description 1
- CIIGWOXXOUVEAD-UHFFFAOYSA-N 2-chloroethyl benzenesulfonate Chemical compound ClCCOS(=O)(=O)C1=CC=CC=C1 CIIGWOXXOUVEAD-UHFFFAOYSA-N 0.000 description 1
- LQLJZSJKRYTKTP-UHFFFAOYSA-N 2-dimethylaminoethyl chloride hydrochloride Chemical compound Cl.CN(C)CCCl LQLJZSJKRYTKTP-UHFFFAOYSA-N 0.000 description 1
- CSDSSGBPEUDDEE-UHFFFAOYSA-N 2-formylpyridine Chemical compound O=CC1=CC=CC=N1 CSDSSGBPEUDDEE-UHFFFAOYSA-N 0.000 description 1
- ZWVHTXAYIKBMEE-UHFFFAOYSA-N 2-hydroxyacetophenone Chemical class OCC(=O)C1=CC=CC=C1 ZWVHTXAYIKBMEE-UHFFFAOYSA-N 0.000 description 1
- ASUDFOJKTJLAIK-UHFFFAOYSA-N 2-methoxyethanamine Chemical compound COCCN ASUDFOJKTJLAIK-UHFFFAOYSA-N 0.000 description 1
- FICAQKBMCKEFDI-UHFFFAOYSA-N 3,5-dimethyl-1,2-oxazole Chemical compound CC=1C=C(C)ON=1 FICAQKBMCKEFDI-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- VSAWBBYYMBQKIK-UHFFFAOYSA-N 4-[[3,5-bis[(3,5-ditert-butyl-4-hydroxyphenyl)methyl]-2,4,6-trimethylphenyl]methyl]-2,6-ditert-butylphenol Chemical compound CC1=C(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(C)=C(CC=2C=C(C(O)=C(C=2)C(C)(C)C)C(C)(C)C)C(C)=C1CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 VSAWBBYYMBQKIK-UHFFFAOYSA-N 0.000 description 1
- ANRMBFFXQKJEIS-UHFFFAOYSA-N 5-(bromomethyl)-3-phenyl-1,2-oxazole Chemical compound O1C(CBr)=CC(C=2C=CC=CC=2)=N1 ANRMBFFXQKJEIS-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- VGCXGMAHQTYDJK-UHFFFAOYSA-N Chloroacetyl chloride Chemical compound ClCC(Cl)=O VGCXGMAHQTYDJK-UHFFFAOYSA-N 0.000 description 1
- SOAHOMVLMUQHSI-UHFFFAOYSA-N Cl.CN(C)CCOC1=CC=CC=C1C=CC1=CC=CC(C)=N1 Chemical compound Cl.CN(C)CCOC1=CC=CC=C1C=CC1=CC=CC(C)=N1 SOAHOMVLMUQHSI-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- UZEUGNPDHSAXJI-UHFFFAOYSA-N N,N-dimethyl-2-[2-[2-(1-methylbenzimidazol-2-yl)ethenyl]phenoxy]ethanamine dihydrochloride Chemical compound Cl.Cl.CN(C)CCOC1=CC=CC=C1C=CC1=NC2=CC=CC=C2N1C UZEUGNPDHSAXJI-UHFFFAOYSA-N 0.000 description 1
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 1
- ZVQOOHYFBIDMTQ-UHFFFAOYSA-N [methyl(oxido){1-[6-(trifluoromethyl)pyridin-3-yl]ethyl}-lambda(6)-sulfanylidene]cyanamide Chemical compound N#CN=S(C)(=O)C(C)C1=CC=C(C(F)(F)F)N=C1 ZVQOOHYFBIDMTQ-UHFFFAOYSA-N 0.000 description 1
- PFCUZDIEKKTHCH-UHFFFAOYSA-N acetonitrile oxide Chemical compound CC#N=O PFCUZDIEKKTHCH-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003288 anthiarrhythmic effect Effects 0.000 description 1
- 230000001387 anti-histamine Effects 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Substances OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 1
- 229940073608 benzyl chloride Drugs 0.000 description 1
- USFRYJRPHFMVBZ-UHFFFAOYSA-M benzyl(triphenyl)phosphanium;chloride Chemical compound [Cl-].C=1C=CC=CC=1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)CC1=CC=CC=C1 USFRYJRPHFMVBZ-UHFFFAOYSA-M 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 238000007265 chloromethylation reaction Methods 0.000 description 1
- KQHLPMCNDYYZMB-UHFFFAOYSA-N chloromethylbenzene;hydrochloride Chemical compound Cl.ClCC1=CC=CC=C1 KQHLPMCNDYYZMB-UHFFFAOYSA-N 0.000 description 1
- USJRLGNYCQWLPF-UHFFFAOYSA-N chlorophosphane Chemical compound ClP USJRLGNYCQWLPF-UHFFFAOYSA-N 0.000 description 1
- 239000012230 colorless oil Substances 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- AIPRAPZUGUTQKX-UHFFFAOYSA-N diethoxyphosphorylmethylbenzene Chemical compound CCOP(=O)(OCC)CC1=CC=CC=C1 AIPRAPZUGUTQKX-UHFFFAOYSA-N 0.000 description 1
- 125000002474 dimethylaminoethoxy group Chemical group [H]C([H])([H])N(C([H])([H])[H])C([H])([H])C([H])([H])O* 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012259 ether extract Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- CNUDBTRUORMMPA-UHFFFAOYSA-N formylthiophene Chemical compound O=CC1=CC=CS1 CNUDBTRUORMMPA-UHFFFAOYSA-N 0.000 description 1
- VXAOKODLROCQJS-UHFFFAOYSA-N furan;hydrochloride Chemical compound Cl.C=1C=COC=1 VXAOKODLROCQJS-UHFFFAOYSA-N 0.000 description 1
- XPFVYQJUAUNWIW-UHFFFAOYSA-N furfuryl alcohol Chemical compound OCC1=CC=CO1 XPFVYQJUAUNWIW-UHFFFAOYSA-N 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002366 halogen compounds Chemical class 0.000 description 1
- 125000004970 halomethyl group Chemical group 0.000 description 1
- 150000003840 hydrochlorides Chemical class 0.000 description 1
- 150000002431 hydrogen Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- PSXRWZBTVAZNSF-UHFFFAOYSA-N hydron;quinoline;chloride Chemical compound Cl.N1=CC=CC2=CC=CC=C21 PSXRWZBTVAZNSF-UHFFFAOYSA-N 0.000 description 1
- KQDJZZWCYTXUDE-UHFFFAOYSA-N hydron;thiophene;chloride Chemical compound Cl.C=1C=CSC=1 KQDJZZWCYTXUDE-UHFFFAOYSA-N 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- YYHIRPUVYUUCTJ-UHFFFAOYSA-N methyl 2-[2-(dimethylamino)ethoxy]benzoate Chemical compound COC(=O)C1=CC=CC=C1OCCN(C)C YYHIRPUVYUUCTJ-UHFFFAOYSA-N 0.000 description 1
- YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- AEXITZJSLGALNH-UHFFFAOYSA-N n'-hydroxyethanimidamide Chemical compound CC(N)=NO AEXITZJSLGALNH-UHFFFAOYSA-N 0.000 description 1
- HCUBLNPEQJJSCC-UHFFFAOYSA-N n,n-dimethyl-2-[2-(2-phenylethenyl)phenoxy]ethanamine Chemical compound CN(C)CCOC1=CC=CC=C1C=CC1=CC=CC=C1 HCUBLNPEQJJSCC-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- OJMIONKXNSYLSR-UHFFFAOYSA-N phosphorous acid Chemical compound OP(O)O OJMIONKXNSYLSR-UHFFFAOYSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920000137 polyphosphoric acid Polymers 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- LJZPPWWHKPGCHS-UHFFFAOYSA-N propargyl chloride Chemical compound ClCC#C LJZPPWWHKPGCHS-UHFFFAOYSA-N 0.000 description 1
- QJZUKDFHGGYHMC-UHFFFAOYSA-N pyridine-3-carbaldehyde Chemical compound O=CC1=CC=CN=C1 QJZUKDFHGGYHMC-UHFFFAOYSA-N 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- BYMVZHORNHZYPQ-UHFFFAOYSA-N sodium;diethyl phosphite Chemical compound [Na+].CCOP([O-])OCC BYMVZHORNHZYPQ-UHFFFAOYSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 1
- RLGKSXCGHMXELQ-ZRDIBKRKSA-N trans-2-styrylquinoline Chemical compound C=1C=C2C=CC=CC2=NC=1\C=C\C1=CC=CC=C1 RLGKSXCGHMXELQ-ZRDIBKRKSA-N 0.000 description 1
- FIQMHBFVRAXMOP-UHFFFAOYSA-N triphenylphosphane oxide Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)(=O)C1=CC=CC=C1 FIQMHBFVRAXMOP-UHFFFAOYSA-N 0.000 description 1
- NCPXQVVMIXIKTN-UHFFFAOYSA-N trisodium;phosphite Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])[O-] NCPXQVVMIXIKTN-UHFFFAOYSA-N 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 238000004383 yellowing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C37/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C39/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
- C07C39/18—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
- C07C39/19—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring containing carbon-to-carbon double bonds but no carbon-to-carbon triple bonds
- C07C39/20—Hydroxy-styrenes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Illuminated Signs And Luminous Advertising (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Description
Denne oppfinnelse angår en analogifremgangsmåt for fremstilling av nye terapeutisk aktive |3-aryl-2-aminoalkoksy-styrener med den generelle formel I This invention relates to an analogous process for the preparation of new therapeutically active |3-aryl-2-amino alkoxystyrenes of the general formula I
og deres fysiologisk forlikelige syreaddisjonssalter med uorganiske og organiske syrer. and their physiologically compatible acid addition salts with inorganic and organic acids.
I denne formel betyr: In this formula means:
Ar en fenylrest, en 2-, 3- eller 4-pyridylrest, som eventuelt kan være substituert med en eller to lavere alkylgrupper, en 2-kinolyl eller 2-pyrazinylrest, som eventuelt kan være substituert med en lavere alkylgruppe, en pyrimidylrest som eventuelt kan være substituert med en lavere alkylgruppe, en 2-benzimidazolylrest som eventuelt kan være substituert med 3t halogenatom og/eller med en lavere alkylgruppe og/eller en trifluormetylgruppe, en 2-furyl- eller 2-tienylrest, en 5-isoksazolylrest som eventuelt kan være substituert med en lavere alkylgruppe eller en fenylgruppe, eller en 5-(1,2,4-oksadiazolyl)-rest som eventuelt kan være substituert med en lavere alkylgruppe, og Ar is a phenyl residue, a 2-, 3- or 4-pyridyl residue, which may optionally be substituted with one or two lower alkyl groups, a 2-quinolyl or 2-pyrazinyl residue, which may optionally be substituted with a lower alkyl group, a pyrimidyl residue which may optionally may be substituted with a lower alkyl group, a 2-benzimidazolyl residue which may optionally be substituted with a 3t halogen atom and/or with a lower alkyl group and/or a trifluoromethyl group, a 2-furyl- or 2-thienyl residue, a 5-isoxazolyl residue which may optionally be substituted with a lower alkyl group or a phenyl group, or a 5-(1,2,4-oxadiazolyl) residue which may optionally be substituted with a lower alkyl group, and
Rl' R2°^ R4 som kan være li^e eller forskjellige, hydrogenatomer eller lavere alkylgruppe, Rl' R2°^ R4 which may be the same or different, hydrogen atoms or lower alkyl group,
R^ et hydrogenatom eller en lavere alkoksygruppe, R^ a hydrogen atom or a lower alkoxy group,
R b og R_/, som er like eller forskjellige, hydrogenatomer eller lavere alkyl-, alkenyl-, hydroksyalkyl-, alkoksyalkyl- eller aralkylrester, R b and R_/, which are the same or different, hydrogen atoms or lower alkyl, alkenyl, hydroxyalkyl, alkoxyalkyl or aralkyl residues,
hvor restene Rg og R^ sammen med det mellomliggende nitrogenatom også kan danne en piperidin-, morfolin- eller metylpiperazinring, og where the residues Rg and R^ together with the intermediate nitrogen atom can also form a piperidine, morpholine or methylpiperazine ring, and
n e~r 0 eller 1. n e~r 0 or 1.
De nye forbindelser med formel I fremstilles i henhold til oppfinnelsen: 1) Ved avspaltning av vann fra forbindelsene med den generelle for mel II The new compounds of formula I are produced according to the invention: 1) By separating water from the compounds with the general flour II
hvor restene Ar, R^ til R^ og n har de ovenfor angitte betydninger. Avspaltningen av vann foretas med egnede midler, f.eks. med fosforsyre, polyfosforsyrer, fpsforsyre med fosforpentoksyd eller svovelsyre; og det har vist seg særlig hensiktsmessig å anvende where the residues Ar, R^ to R^ and n have the meanings indicated above. The separation of water is carried out with suitable means, e.g. with phosphoric acid, polyphosphoric acids, phosphoric acid with phosphorous pentoxide or sulfuric acid; and it has proven particularly appropriate to use
85&ig fos forsyre. Reaksj onen foregår ved forhøyede temperaturer, :;■'[ fortrinnsvis i området mellom 70 og 130°C. 2) Ved omsetning av en fosfonsyreester med den generelle formel III, hvor og Ar har de ovenfor angitte betydninger, og Rg er en lavere alkylrest, med et aldehyd eller keton med den generelle formel IV 85&ig phos foracid. The reaction takes place at elevated temperatures, preferably in the range between 70 and 130°C. 2) When reacting a phosphonic acid ester with the general formula III, where and Ar have the meanings given above, and Rg is a lower alkyl residue, with an aldehyde or ketone of the general formula IV
hvor restene R2 til R? og n har de ovenfor angitte, betydninger, where the residues R2 to R? and n have the above meanings,
i nærvær av^en base'under intermediær dannelse av det tilsvarende ■ karbanion av forbindelsen med formel III.. Som baser foretrekkes alkal ihy dr ider... r s; • Omsetningen foretas i epplØsningsmidler^ Som: oppløsnings ^; midler er særlig egnet høytkokende etere, f .eks. dioksan. Om- , v setningen'kan også foretas i et-vannholdig oppløsningsmiddel, fTéksf i metanol/vann i nærvær av en uorganisk base.. Hensikts- - in the presence of^a base'under intermediate formation of the corresponding ■ carbanion of the compound of formula III.. Preferred bases are alkali ihy dr ider... r s; • The turnover is made in apple solvents^ Such as: dissolving ^; agents are particularly suitable high-boiling ethers, e.g. dioxane. The reaction can also be carried out in an aqueous solvent, e.g. in methanol/water in the presence of an inorganic base.
messig settes alkalihydridet først til fosfonsyreesteren med den generelle formel III. Etter at hydrogenutvikiingen er opphørt tilsettes hensiktsmessig aldehydet eller ketonet med formel IV conventionally, the alkali hydride is first added to the phosphonic acid ester of the general formula III. After the hydrogen evolution has ceased, the aldehyde or ketone of formula IV is suitably added
uten at det dannede karbanion isoleres på forhånd. Omsetningen foretas ved svakt forhøyede temperaturer, fortrinnsvis ved temperaturer mellom 30 og 60°C. without the formed carbanion being isolated in advance. The reaction is carried out at slightly elevated temperatures, preferably at temperatures between 30 and 60°C.
3) Ved omsetning av en fosfonsyreester med den generelle formel V 3) When reacting a phosphonic acid ester with the general formula V
O = P(OR ) .0°0£I po OT fliolløæ isbexocto i a.rinwu-j:x;\toX O = P(OR ) .0°0£I po OT fliolløæ isbexocto i a.rinwu-j:x;\toX
,111 isnrio3. slls^ns^ rffeb bøni :ta;*8sei ya«©5ao2 ne vs £.a.i irs s £:;;;,3 -■ ■.>/ ,111 isnrio3. slls^ns^ rffeb böni :ta;*8sei ya«©5ao2 ne vs £.a.i irs s £:;;;,3 -■ ■.>/
hvor restene R2 til R7 og n har de ovenfor angitte betydning^^ og Rn betyr en lavere alkylres£, med et aldehyd eller keton med den generelle formel VI ^~-->/' \ hvor Ar og S.^ er som ovenfor angitt,^i nærvær av en base under intermediær dannelse av et karbanion av forbindelsen med formel V. Srøpfeas.ef^re^ek^es iføg .„ pQ ^ ^ ^ 3n9.t3_ .£ev,,. J^l igt ^np^^h^t^o^e^^ex^^om^f .^Xs^ dioks an . Omsetningen kan imidlertid også utføres i et vannholdig opp-'.uoaa8*nia!fief*s^r..ax9.j .s*e4a.eJWo*rY*rf ^røa riXtw*--» -a/bbn iejf) o^aphøfetrr^M^j^ .rtje.4 formel VI uten f otii^gåfi.n de, isjq^råag^^j^f^^^ap^fd Qx,.karban i on av r forbin de1s en mé&. fToæmej& Vvsm Omsetningen- rut4øre.S;_.yed svakt forhøyede temperaturer, fCM<p>bcintoswi^ yedtBtjemneraturer fm§llom ;.3.0 og..60.C. 4) Véd.\oms-.e.t»ing; javlet-.styren ^med Hden generelle formel VII hvor restene Ar, R^^ til R3 er som ovenfor angitt, og X betyr et hydrogenatom eller en acetylgruppe, med et amin med den generelle formel VIII where the residues R2 to R7 and n have the meanings indicated above^^ and Rn means a lower alkyl residue, with an aldehyde or ketone of the general formula VI ^~-->/' \ where Ar and S.^ are as indicated above ,^in the presence of a base during intermediate formation of a carbanion of the compound of formula V. Srøpfeas.ef^re^ek^es added .„ pQ ^ ^ ^ 3n9.t3_ .£ev,,. J^l igt ^np^^h^t^o^e^^ex^^om^f .^Xs^ dioks an . However, the reaction can also be carried out in an aqueous solution. ^aphøfetrr^M^j^ .rtje.4 formula VI without f otii^gåfi.n de, isjq^råag^^j^f^^^ap^fd Qx,.karban i on av r forbin de1s en mé&. fToæmej& Vvsm The turnover- rut4øre.S;_.yed slightly elevated temperatures, fCM<p>bcintoswi^ yedtBtjemneratures fm§llom ;.3.0 and..60.C. 4) Véd.\oms-.e.t»ing; styrene with the general formula VII where the radicals Ar, R^^ to R3 are as indicated above, and X means a hydrogen atom or an acetyl group, with an amine of the general formula VIII
hvor restene R4 til R? har de ovenfor angitte.betydninger, og Y betyr et halogenatom, i nærvær av en base. where the residues R4 to R? has the meanings given above, and Y means a halogen atom, in the presence of a base.
Omsetningen foretas i inerte oppløsnihgsmidler som f.eks. benzen, ' klorbenzen, toluen, xylen og ved forhøyede temperaturer, fortrinnsvis ved det anvendte oppløsningsmiddels kokepunkt. Som baser kan f.eks. anvendes alkalihydroksyder eller -karbonater, fortrinnsvis imidlertid alkalialkoholater. The turnover is carried out in inert solvents such as e.g. benzene, 'chlorobenzene, toluene, xylene and at elevated temperatures, preferably at the boiling point of the solvent used. As bases, e.g. alkali hydroxides or carbonates are used, preferably, however, alkali alcoholates.
5) Ved omsetning av en forbindelse med-den-generelle formel IX 5) When converting a compound with the general formula IX
hvor restene Ar, til R^ og n har de ovenfor angitte betydninger, og Z betyr en rest som kan utskiftes med basiske rester, som f.eks. et halogenatom eller en tosylgruppe, med et amin med den generelle formel X where the residues Ar, to R^ and n have the meanings given above, and Z means a residue that can be replaced by basic residues, such as e.g. a halogen atom or a tosyl group, with an amine of the general formula X
hvor restene Rg og R7 er som ovenfor angitt. where the residues Rg and R7 are as indicated above.
Omsetningen gjennomføres i et oppløsningsmiddel i nærvær The reaction is carried out in the presence of a solvent
av et syrebindende middel. Som syrebindende middel kan anvendes uorganiske eller organiske baser eller også et overskudd av aminet med formel X, og sistnevnte kan samtidig også tjene som oppløsnings-middel. Omsetningen utføres ved forhøyede temperaturer, vanligvis ved temperaturer mellom 60 og 120°C. Hvis det anvendes et lett-flyktig amin med formel X, utføres omsetningen hensiktsmessig i et lukket kar. of an acid-binding agent. Inorganic or organic bases or an excess of the amine of formula X can be used as acid-binding agent, and the latter can also serve as a solvent at the same time. The reaction is carried out at elevated temperatures, usually at temperatures between 60 and 120°C. If a highly volatile amine of formula X is used, the reaction is conveniently carried out in a closed vessel.
6) Ved omsetning av fosforylider med den generelle formel XI 6) In the reaction of phosphorylides with the general formula XI
hvor Ar og er som ovenfor angitt, med basiske ketoner eller aldehyder med formel IV where Ar and are as indicated above, with basic ketones or aldehydes of formula IV
hvor restene R2 til R^ og n har de ovenfor angitte betydninger. Kort før de omsettes, frigjøres fosforylidene med den generelle formel XI fra de tilsvarende fosfoniumhalogenider ved hjelp av baser, f.eks. ved hjelp av alkalialkoholater. Omsetningen foretas i et oppløsningsmiddel, f.eks. i en alkohol så som etanol. Omsetningen foregår ved forhøyet temperatur mellom 40°C og det anvendte oppløsningsmiddels kokepunkt. where the residues R 2 to R 1 and n have the meanings given above. Shortly before they are reacted, the phosphorylides of the general formula XI are liberated from the corresponding phosphonium halides by means of bases, e.g. by means of alkali alcoholates. The reaction is carried out in a solvent, e.g. in an alcohol such as ethanol. The reaction takes place at an elevated temperature between 40°C and the boiling point of the solvent used.
Forbindelsene med formel I dannes i almindelighet som blandinger av sine cis- og trans-isomerer. Hvis R^ og R ? er hydrogenatomer ved fremgangsmåtealternativene 1,2, 3 og 6, dannes overveiende trans-forbindelsene. Cis- og trans-forbindelsene, særlig saltene derav, f.eks. hydrokloridene, kan adskilles fra hverandre ved fraksjonert krystallisasjon. The compounds of formula I are generally formed as mixtures of their cis and trans isomers. If R^ and R ? are hydrogen atoms in method alternatives 1,2, 3 and 6, predominantly the trans compounds are formed. The cis and trans compounds, especially their salts, e.g. the hydrochlorides, can be separated from each other by fractional crystallization.
Forbindelsene med formel I kan overføres på vanlig måte The compounds of formula I can be transferred in the usual way
til sine syreaddisjonssalter ved hjelp av uorganiske eller organiske syrer. Hvis Ar betyr en N-inneholdende heterocyklisk gruppe, er det mulig ved trinnvis nøytralisasjon å tilleire et proton bare på nitrogenatomet i den basiske sidekjede. Hvis man arbeider med et overskudd av syre, får man også saltdannelse med nitrogenatomene i de heterocykliske ringer. Som syrer er særlig egnet saltsyre, bromhydrogensyre, svovelsyre, fosforsyre, vinsyre, p-toluensulfonsyre. to their acid addition salts using inorganic or organic acids. If Ar means an N-containing heterocyclic group, it is possible by stepwise neutralization to deposit a proton only on the nitrogen atom of the basic side chain. If you work with an excess of acid, you also get salt formation with the nitrogen atoms in the heterocyclic rings. Particularly suitable acids are hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid, tartaric acid, p-toluenesulfonic acid.
De forbindelser med den generelle formel II som anvendes, som utgangsmaterialer ved fremgangsmåtealternativ 1), fremstilles som følger: The compounds with the general formula II which are used as starting materials in process alternative 1) are prepared as follows:
En forbindelse med den generelle formel XIII, kondenseres med en ester med den generelle formel XIV til-et keton med den generelle formel XV f.eks. ved hjelp av natriumamid i toluen. Ketonet med den generelle formel XV reduseres deretter med komplekse hydrider, f.eks. med natriumborhydrid eller med katalytisk dannet hydrogen, til alkoholen med den generelle formel II. I formlene XIII til XV har restene til R^ og n de ovenfor angitte betydninger, og resten Rg betyr en alkylrest. Fosfonsyreestrene med den generelle formel III som anvendes ved fremgangsmåtealternativ 2, kan fremstilles ved omsetning av halogenmetylforbindelser med den generelle formel XVI A compound of the general formula XIII is condensed with an ester of the general formula XIV to a ketone of the general formula XV e.g. using sodium amide in toluene. The ketone of general formula XV is then reduced with complex hydrides, e.g. with sodium borohydride or with catalytically formed hydrogen, to the alcohol of the general formula II. In the formulas XIII to XV, the residues of R 1 and n have the meanings given above, and the residue R 2 means an alkyl residue. The phosphonic acid esters with the general formula III that are used in process alternative 2 can be prepared by reacting halomethyl compounds with the general formula XVI
hvor Ar og R1 er som ovenfor angitt, og Hal betyr et klor-, brom-eller jodatom, med trialkylfosfit ved metoden ifølge Arbusow - Michaelis (Houben-Weyl, Methoden der organischen Chemie, 4. oppi. Vol. XII, del 1, S. 433) eller med dialkylfosfitnatrium ved metoden where Ar and R1 are as indicated above, and Hal means a chlorine, bromine or iodine atom, with trialkyl phosphite by the method according to Arbusow - Michaelis (Houben-Weyl, Methoden der organischen Chemie, 4. oppi. Vol. XII, part 1, P. 433) or with dialkyl phosphite sodium by the method
ifølge Michaelis-Becker (Houben-Weyl, Methoden der organischen Chemie, 4. oppi. Vol. XII, del 1, s. 447). according to Michaelis-Becker (Houben-Weyl, Methoden der organischen Chemie, 4. oppi. Vol. XII, part 1, p. 447).
Forbindelsene med den generelle formel IV fremstilles ved basisk alkylering av forbindelser med den generelle formel The compounds of the general formula IV are prepared by basic alkylation of compounds of the general formula
ved hjelp av forbindelser med den generelle formel VIII ved hjelp av den i fremgangsmåtealternativ 4 angitte metode. Man fremstilte således de følgende forbindelser fra de tilsvarende salicylaldehyder eller 2-hydroksyacetofenoner: 2-(2-dimetylaminoetoksy)-benzaldehyd, k.p._ nc. = 110°C 2-(2-dimetylaminoetoksy)-acetofenon, k.p.Q ' Q^ = 103-105 oC 2-(3-dimetylaminopropoksy)-benzaldehyd k.p.Q Qg = 109-112°C 2-(3-dimetylaminopropoksy)-acetofenon, k.p.Q ^ = 130 C Fosfonsyreestrene med den generelle formel V som anvendes ved fremgangsmåtealternativ 3, kan fremstilles på følgende måte: Ved basisk alkylering av forbindelser med den generelle formel XVII med forbindelser med den generelle formel VIII får man ketoner eller aldehyder med den generelle formel IV. Disse omsettes med komplekse hydrider, fortrinnsvis med natriumborhydrid i metanol til de tilsvarende alkoholer og disse deretter med uorganiske syrehalogenider, f.eks.' med tionylklorid, til de tilsvarende halogenforbindelser med den generelle formel XVIII by means of compounds of the general formula VIII by means of the method indicated in method alternative 4. The following compounds were thus prepared from the corresponding salicylaldehydes or 2-hydroxyacetophenones: 2-(2-dimethylaminoethoxy)-benzaldehyde, m.p._nc. = 110°C 2-(2-dimethylaminoethoxy)-acetophenone, b.p.Q ' Q^ = 103-105 oC 2-(3-dimethylaminopropoxy)-benzaldehyde b.p.Q Qg = 109-112°C 2-(3-dimethylaminopropoxy)-acetophenone, b.p.Q ^ = 130 C The phosphonic acid esters with the general formula V used in process alternative 3 can be prepared in the following way: By basic alkylation of compounds with the general formula XVII with compounds with the general formula VIII, ketones or aldehydes with the general formula IV are obtained . These are reacted with complex hydrides, preferably with sodium borohydride in methanol to the corresponding alcohols and these then with inorganic acid halides, e.g. with thionyl chloride, to the corresponding halogen compounds of the general formula XVIII
hvor restene R2 til R7 og n har de ovenfor angitte betydninger, og Hal betyr et halogenatom, fortrinnsvis et klor- eller bromatom. Forbindelsene med formel XVIII utfelles vanligvis i godt krystallisert tilstand, og foreligger som halogenhydrogensure where the radicals R 2 to R 7 and n have the meanings given above, and Hal means a halogen atom, preferably a chlorine or bromine atom. The compounds of formula XVIII usually precipitate in a well-crystallized state, and are present as halogen hydrogen acids
salter. Disse salter omsettes i et inert oppløsningsmiddel, som f.eks. i benzen, med den pr. mol beregnede dobbelte mengde av di-alkylfosfit-natrium ved metoden ifølge Michaelis-Becker (Houben- salts. These salts are reacted in an inert solvent, such as e.g. in benzene, with the pr. mol calculated twice the amount of di-alkyl phosphite sodium by the method according to Michaelis-Becker (Houben-
Weyl, Methoden der organischen Chemie, 4. oppi., Vol. XII, del 1, Weyl, Methoden der organischen Chemie, 4. oppi., Vol. XII, part 1,
s. 447) til forbindelser med den generelle formel V. p. 447) to compounds of the general formula V.
Forbindelsene med den generelle formel VII som anvendes ved fremgangsmåtealterantiv 4, kan fremstilles ved anvendelse av kjente metoder (jfr. L. Horwitz, J. Org. Chem. 21, 1039-1041 [1956]). Forbindelsene med den generelle formel VIII er kjent fra litteraturen eller de kan fremstilles i analogi med kjente metoder. The compounds of the general formula VII used in process alternative 4 can be prepared using known methods (cf. L. Horwitz, J. Org. Chem. 21, 1039-1041 [1956]). The compounds of the general formula VIII are known from the literature or they can be prepared by analogy with known methods.
Utgangsforbindelsene med den generelle formel IX som anvendes ved fremgangsmåtealternativ 5, kan fremstilles f.eks. ved omsetning av de tilsvarende 2- (2-acetoksystyryl)-arytforbindelser med benzensul-fonsyre-2-halogenetylestere i nærvær av kaliummetylat i toluen. Således ble f.eks. de følgende utgangsforbindelser fremstilt: 2-[2-(2-kloretoksy)styryl]-pyridin, sm.p. 57-59°C, The starting compounds with the general formula IX used in process alternative 5 can be prepared, e.g. by reacting the corresponding 2-(2-acetoxystyryl)-aryt compounds with benzenesulfonic acid 2-haloethyl esters in the presence of potassium methylate in toluene. Thus, e.g. the following starting compounds prepared: 2-[2-(2-chloroethoxy)styryl]-pyridine, m.p. 57-59°C,
2-[2-(2-kloretoksy)styryl]-kinolin, sm.p. av hydrokloridet 200-202°C. 2-[2-(2-chloroethoxy)styryl]-quinoline, m.p. of the hydrochloride 200-202°C.
Fosfoniumhalogenidene som ligger til grunn for fosforylidene med formel XI som anvendes ved fremgangsmåtealternativ 6, fremstilles ved innvirkning av trifenylfosfin på halogenmetylforbindelsem med den generelle formel The phosphonium halides which form the basis of the phosphorylides of formula XI used in process alternative 6 are produced by the action of triphenylphosphine on the halogenmethyl compound of the general formula
Således ble f.eks. (3,5-dimetyl-isoksazolyl-4)-metyl-trifenylfosfon-iumklorid fremstilt fra 3,5-dimetyl-4-klormetylisoksazol og trifenyl-fosf in i et utbytte på 89% av det teoretiske i form av fargeløse krystaller. Thus, e.g. (3,5-dimethyl-isoxazolyl-4)-methyl-triphenylphosphonium chloride prepared from 3,5-dimethyl-4-chloromethylisoxazole and triphenyl-phosphine in a yield of 89% of the theoretical in the form of colorless crystals.
Forbindelsene med den generelle formel I er i besittelse av verdifulle farmakologiske "egenskapr. De virker særlig smertestillende uten de bivirkninger som morfin har, og dessuten har de en god bedøv-ende og muskelavslappende virkning. . Den forbindelse som er funnet å ha best smertestillende og antiarytmisk virkning, er 2-[o-(2-dimetylaminoetoksy)styryl]-pyridin og salter av denne. The compounds of the general formula I possess valuable pharmacological properties. They have a particularly analgesic effect without the side effects of morphine, and furthermore they have a good anesthetic and muscle relaxant effect. The compound which has been found to have the best analgesic and antiarrhythmic action, is 2-[o-(2-dimethylaminoethoxy)styryl]-pyridine and its salts.
For den fysiologiske virkning er o-stillingen for den basiske sidekjede på benzenkjernen vesentlig. Således er f.eks. de kjente, isomere 4-aminoalkoksystyrener (jfr. Cavallini et al. Il Farmaco, Ed. Sei. 9, 405415 [1954] og P. Montegazza et al., For the physiological effect, the o-position of the basic side chain on the benzene nucleus is essential. Thus, e.g. the known, isomeric 4-aminoalkoxystyrenes (cf. Cavallini et al. Il Farmaco, Ed. Sei. 9, 405415 [1954] and P. Montegazza et al.,
Arch. intern, pharmacodyn. 103, 371-309) overhodet ikke smertestillende. I henhold til litteraturen har disse en antinikotin- Arch. internal, pharmacodyn. 103, 371-309) not a painkiller at all. According to the literature, these have an antinicotine
og antihistamin-virkning. and antihistamine effect.
Forbindelsene med den generelle formel I ble undersøkt The compounds of the general formula I were investigated
med hensyn til sin smertestillende virkning ved varmeplatemetoden ifølge Chen og. Beckmånn, Science 113, 1951, side 631. Grupper på hver 10 mus ble da utsatt for en varmesmerte ved å bli anbrakt på with regard to its analgesic effect by the hot plate method according to Chen et. Beckmånn, Science 113, 1951, page 631. Groups of every 10 mice were then exposed to a heat pain by being placed on
en varmeplate med en temperatur på 56°C. Dyrene som ble anvendt ved forsøket, reagerte normalt i løpet av 20 sekunder. Den smertestillende virkning ble bedømt etter den prosentdel av forsøks-dyrene som ikke reagerte ved en bestemt dose i løpet av 50 sekunder. Verdien ED^q representerer således den dose som bevirker at 50% av musene ikke reagerer på varmesmerten etter administreringen. De aktive forbindelser ble administrert peroralt. De nye forbindelser er bare lite toksiske. Den akutte toksisitet ble bestemt på mus. Grupper på hver 10 mus fikk administrert i økende doser den a hot plate with a temperature of 56°C. The animals used in the experiment reacted normally within 20 seconds. The analgesic effect was judged by the percentage of experimental animals that did not react at a certain dose within 50 seconds. The value ED^q thus represents the dose which causes 50% of the mice not to react to the heat pain after administration. The active compounds were administered orally. The new compounds are only mildly toxic. The acute toxicity was determined in mice. Groups of 10 mice each were administered increasing doses of it
aktive forbindelse peroralt. Verdien LD^Q, dvs. den dose som førte til at 50% av musene døde innen 14 dager etter administreringen, active compound orally. The LD^Q value, i.e. the dose that caused 50% of the mice to die within 14 days of administration,
ble beregnet på grunnlag av de fundne verdier ved metoden ifølge Litchfield og Wilcoxon. was calculated on the basis of the values found by the method according to Litchfield and Wilcoxon.
De følgende forbindelser er særlig sterkt smertestillende: 2- 12-(2-dimetylaminoetoksy)styrylIpyrazin-monohydroklorid; 2-[2-(2-dimetylaminoetoksy)styrylJkinolin-monohydroklorid, 2- 12-(2-dimetylaminoetoksy)styryl[-6-metyl-pyridin-monohydroklorid, 2-t 2-(2-dimetylaminoetoksy)styryllpyridin-monohydroklorid, 5-{[ 2-(2-dimetylamino)etoksy]-styryl} -3-metyl-isoksazol-hydroklorid, 5-[[2-(2-dimetylamino)etoksy]-styryl} -3-fenyl-isoksazol-hydroklorid, 2-[2-(2-dimetylaminoetoksy)styryl]-1-metylbenzimidazol-dihydroklorid, 2-(2-dimetylaminoetoksy)-stilben-hydroklorid 2- 12-(2-dimetylaminoetoksy)styrylI-furan-hydroklorid, 2-12-(2-dimetylaminoetoksy)styryl]-tiofen-hydroklorid, 1- (2-dimetylaminoetoksyfenyl)-2-(pyridyl-2-)-propen-l-monohydro-klorid, The following compounds are particularly strong analgesics: 2-12-(2-dimethylaminoethoxy)styrylpyrazine monohydrochloride; 2-[2-(2-dimethylaminoethoxy)styrylJquinoline monohydrochloride, 2- 12-(2-dimethylaminoethoxy)styryl[-6-methyl-pyridine monohydrochloride, 2-t 2-(2-dimethylaminoethoxy)styrylpyridine monohydrochloride, 5- {[ 2-(2-dimethylamino)ethoxy]-styryl}-3-methyl-isoxazole hydrochloride, 5-[[2-(2-dimethylamino)ethoxy]-styryl}-3-phenyl-isoxazole hydrochloride, 2- [2-(2-Dimethylaminoethoxy)styryl]-1-methylbenzimidazole dihydrochloride, 2-(2-dimethylaminoethoxy)stilbene hydrochloride 2- 12-(2-dimethylaminoethoxy)styrylI-furan hydrochloride, 2-12-(2- dimethylaminoethoxy)styryl]thiophene hydrochloride, 1-(2-dimethylaminoethoxyphenyl)-2-(pyridyl-2-)-propene-1-monohydrochloride,
2- [2-(2-metylaminoetoksy)styryl]pyridin-dihydroklorid og 2-[2-(2-morfolinoetoksy)styryl]pyridin-dihydroklorid. 2-[2-(2-methylaminoethoxy)styryl]pyridine dihydrochloride and 2-[2-(2-morpholinoethoxy)styryl]pyridine dihydrochloride.
Forbindelsene har ved peroral administrering en ED5Q mellom 10 og When administered orally, the compounds have an ED5Q between 10 and
60 mg/kg mus. Forbindelsene er bare lite toksiske, og således ligger f.eks. LD50-verdiene for følgende forbindelser mellom 500 60 mg/kg mouse. The compounds are only mildly toxic, and thus e.g. The LD50 values for the following compounds between 500
og 800 mg/kg mus: 2-[2-(2-dimetylaminoetoksy)styryl]-1-metyl-benzimidazol-dihydroklorid, and 800 mg/kg mouse: 2-[2-(2-dimethylaminoethoxy)styryl]-1-methyl-benzimidazole dihydrochloride,
2-(2-dimetylaminoetoksy)-stilben-hydroklorid 2-(2-Dimethylaminoethoxy)-stilbene hydrochloride
2-[2-(2-morfolinoetoksy)styryl]pyridin-dihydroklorid og 2-[2-(2-dimetylaminoetoksy)styryl]6-metyl-pyridin-hydroklorid. 2-[2-(2-morpholinoethoxy)styryl]pyridine dihydrochloride and 2-[2-(2-dimethylaminoethoxy)styryl]6-methylpyridine hydrochloride.
Eksempel 1 Example 1
20,2 g l-pyrazinyl-2-(2-dimetylaminoetoksyfenyl)-etanol-2 omrøres med 60 ml 85%ig fosforsyre, hvorved blandingen oppvarmes til 70°C. Man oppvarmer deretter i 1 time ved 110°C, oppløser blandingen i 300 ml vann etter avkjøling, nøytraliserer og metter med kaliumkarbonat. Det dannede reaksjonsprbdukt ekstraheres deretter 3 ganger med 50 ml eter hver gang, tørres over vannfritt kaliumkarbonat og filtreres med kull. Fordampningsresiduet destilleres i vakuum. Man får 13,25 g (svarende til 70,2% av det teoretiske) av en lysegul olje med kokepunkt k.p.Q 143-150°C. Oljen oppløses i 250 ml aceton og tilsettes forsiktig så mye av en oppløsning av hydrogenkloridgass i aceton at en gulfarvning akkurat begynner. Etter avkjøling i isbad utskilles hvite krystaller, 20.2 g of 1-pyrazinyl-2-(2-dimethylaminoethoxyphenyl)-ethanol-2 is stirred with 60 ml of 85% phosphoric acid, whereby the mixture is heated to 70°C. It is then heated for 1 hour at 110°C, the mixture is dissolved in 300 ml of water after cooling, neutralized and saturated with potassium carbonate. The reaction product formed is then extracted 3 times with 50 ml of ether each time, dried over anhydrous potassium carbonate and filtered with charcoal. The evaporation residue is distilled in vacuum. You get 13.25 g (corresponding to 70.2% of the theoretical) of a pale yellow oil with a boiling point c.p.Q 143-150°C. The oil is dissolved in 250 ml of acetone and carefully added enough of a solution of hydrogen chloride gas in acetone that a yellow coloration just begins. After cooling in an ice bath, white crystals are separated,
og denne mengde økes ved innrøring av 150 ml eter. Etter avsugning og tørring får man 13,9 g (svarende til 88,2% av det teoretiske basert på hydrokloriddannelsen) av 2-[2-(2-dimetylaminoetoksy)-styrylIpyrazin-monohydroklorid med sm.p. 194-195°C. and this quantity is increased by stirring in 150 ml of ether. After suction and drying, 13.9 g (corresponding to 88.2% of the theoretical based on the hydrochloride formation) of 2-[2-(2-dimethylaminoethoxy)-styrylpyrazine monohydrochloride with m.p. 194-195°C.
Den som utgangsmateriale anvendte 1-(pyrazinyl-2-)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, en ikke destillerbar, gul. olje, ensartet i tynnsjiktkromatogram, fremstilles av (pyrazinyl-2-)-(2-dimetylaminoetoksyfenyl)-keton (ikke-destillerbar olje, danner et krystallisert litiumenolat) ved reduksjon med natriumborhydrid. Det nødvendige keton fremstilles av 2-metylpyrazin og 2-dimetylaminoetoksybenzoesyre-metylester ved kondensasjon med natriumamid i toluen. It used as starting material 1-(pyrazinyl-2-)-2-(2-dimethylaminoethoxyphenyl)-ethanol-2, a non-distillable, yellow. oil, uniform in thin-layer chromatogram, is prepared from (pyrazinyl-2-)-(2-dimethylaminoethoxyphenyl)-ketone (non-distillable oil, forms a crystallized lithium enolate) by reduction with sodium borohydride. The necessary ketone is prepared from 2-methylpyrazine and 2-dimethylaminoethoxybenzoic acid methyl ester by condensation with sodium amide in toluene.
Analogt med fremgangsmåten beskrevet i eksempel 1 fremstilles de følgende forbindelser (eksempel 2-7). Analogous to the method described in example 1, the following compounds are prepared (examples 2-7).
Eksempel 2 Example 2
Av 1-(kinolyl-2)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, Of 1-(quinolyl-2)-2-(2-dimethylaminoethoxyphenyl)-ethanol-2,
en gul, ikke-destillerbar olje, ensartet i tynnsjiktkromatogram, fremstilles 2-t2-(2-dimetylaminoetoksy)styryl]-kinolin-monohydro-klorid med sm.p. 188°C i et utbytte på 87%. a yellow, non-distillable oil, uniform in thin-layer chromatogram, 2-t2-(2-dimethylaminoethoxy)styryl]-quinoline monohydrochloride is prepared with m.p. 188°C in a yield of 87%.
Eksempel 3 Example 3
Av 1-(6-metyl-pyridyl-2)-2-(o-dimetylaminoetoksyfenyl)-etanol-2 (lysegule krystaller, sm.p. = 228°C) fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-6-metylpyridinmonohydroklorid med From 1-(6-methyl-pyridyl-2)-2-(o-dimethylaminoethoxyphenyl)-ethanol-2 (light yellow crystals, m.p. = 228°C) 2-[2-(2-dimethylaminoethoxy)styryl] is prepared -6-methylpyridine monohydrochloride with
smeltepunkt 200°C i et utbytte på 20%. melting point 200°C in a yield of 20%.
Eksempel 4 Example 4
Av 1(4,6-dimetylpyridyl-2)-2-(o-dimetylaminoetoksyfenyl)-etanol-2 (lysegul, ikke-destillerbar olje, ensartet i tynnsjiktkromatogram fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-4,6-dimetylpyridindihydroklorid med smeltepunkt 177°c i et utbytte på 81%. 2-[2-(2-dimethylaminoethoxy)styryl]-4 is prepared from 1(4,6-dimethylpyridyl-2)-2-(o-dimethylaminoethoxyphenyl)-ethanol-2 (light yellow, non-distillable oil, uniform in thin-layer chromatogram), 6-dimethylpyridine dihydrochloride with melting point 177°c in a yield of 81%.
Eksempel 5 Example 5
Av 1-(2-pyridyl)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, Of 1-(2-pyridyl)-2-(2-dimethylaminoethoxyphenyl)-ethanol-2,
en gul, ikke-destillerbar, i tynnsjiktkromatogram ensartet olje, fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]pyridinmonohydro- a yellow, non-distillable, thin-layer chromatogram uniform oil, 2-[2-(2-dimethylaminoethoxy)styryl]pyridine monohydro-
klorid med smeltepunkt 183°C i et utbytte på 88%. chloride with melting point 183°C in a yield of 88%.
Eksempel 6 Example 6
Av 1-(5-metylpyrazinyl-2)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, en fargeløs, ikke-destillerbar, i tynnsjiktkromatogram ensartet olje, fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-5-metylpyrazin-2-dihydroklorid, en harpiksaktig, hvit substans, From 1-(5-methylpyrazinyl-2)-2-(2-dimethylaminoethoxyphenyl)-ethanol-2, a colorless, non-distillable, thin-layer chromatogram uniform oil, 2-[2-(2-dimethylaminoethoxy)styryl]-5 -methylpyrazine-2-dihydrochloride, a resinous, white substance,
ensartet i tynnsjiktkromatogram i et utbytte på 65%. uniform in thin-layer chromatogram in a yield of 65%.
Eksempel 7 Example 7
Av 1-(4-metylpyrimidyl-6)-2-(2-dimetylaminoetoksyfenyl)-etanol-2, en ikke-destillerbar, klar, gul olje, ensartet i tynnsjiktkromatogram; fremstilles 6-[2-(2-dimetylaminoetoksy)-styryl]-4-metyl-pyrimidin med smeltepunkt 234°C i et utbytte på From 1-(4-methylpyrimidyl-6)-2-(2-dimethylaminoethoxyphenyl)ethanol-2, a non-distillable, clear, yellow oil, uniform in thin-layer chromatogram; 6-[2-(2-dimethylaminoethoxy)-styryl]-4-methyl-pyrimidine with a melting point of 234°C is produced in a yield of
87%. 87%.
Eksempel 8 Example 8
12 g av en 50%ig:'suspens jon av natriumhydrid i paraffinolje befries for vedheftende paraffinolje ved dekantering to ganger med dioksan og suspenderes i 100 ml absolutt dioksan. Denne suspensjon innføres under omrøring porsjonsvis i en oppløsning av 54 g 3-metylisoksazolyl-5-metylfosfonsyredietylester i 200 ml vannfritt dioksan, oppvarmet til en temperatur på 40 C. Etter avsluttet hydrogenutvikling omrøres i 1 time ved 50°C. Etter avkjøling til romtemperatur tilsettes dråpevis 40 g 2-(2-dimetylamino)-etoksy-benzaldehyd, og deretter oppvarmes i 1 time ved 50°C. Reaksjonsblandingen helles på is, surgjøres med 2N saltsyre og ekstraheres med eter. Eterekstrakteri kastes, den vandige fase gjøres alkalisk med fortynnet natronlut og ekstraheres med eter. Det oljeaktige residuum som man får etter tørring over natriumsulfat og avdampning av eteren, opptas i etanol, behandles med aktivt kull og tilsettes eterisk saltsyre. Etter to gangers omkrystallisering fra etanoi/ eter får man 45 g (70,5% av det teoretiske) 5-[o-(2-dimetylamino)-etoksy]styryl-3-metylisoksazol-hydroklorid i form av svakt gule krystaller med smeltepunkt 150-151°C. 12 g of a 50% suspension of sodium hydride in paraffin oil are freed from adhering paraffin oil by decanting twice with dioxane and suspended in 100 ml of absolute dioxane. This suspension is introduced, while stirring, in portions into a solution of 54 g of 3-methylisoxazolyl-5-methylphosphonic acid diethyl ester in 200 ml of anhydrous dioxane, heated to a temperature of 40°C. After completion of hydrogen evolution, stir for 1 hour at 50°C. After cooling to room temperature, 40 g of 2-(2-dimethylamino)-ethoxy-benzaldehyde are added dropwise, and then heated for 1 hour at 50°C. The reaction mixture is poured onto ice, acidified with 2N hydrochloric acid and extracted with ether. Ether extraction is discarded, the aqueous phase is made alkaline with dilute caustic soda and extracted with ether. The oily residue obtained after drying over sodium sulphate and evaporation of the ether is taken up in ethanol, treated with activated charcoal and ethereal hydrochloric acid is added. After two recrystallizations from ethanol/ether, 45 g (70.5% of the theoretical) of 5-[o-(2-dimethylamino)-ethoxy]styryl-3-methylisoxazole hydrochloride are obtained in the form of pale yellow crystals with a melting point of 150 -151°C.
Utgangsmaterialet 3-metylisoksazolyl-5-metylfosfonsyre-dietylester fremstilles i et utbytte på 84% av .det teoretiske fra 3-metyl-5-klormetylisoksazol og trietylfosfit som en gul olje med k.p. 76-80°C ved 0,0015 mm Hg. The starting material 3-methylisoxazolyl-5-methylphosphonic acid diethyl ester is prepared in a yield of 84% of the theoretical from 3-methyl-5-chloromethylisoxazole and triethyl phosphite as a yellow oil with b.p. 76-80°C at 0.0015 mm Hg.
Forbindelsen 3-metyl-5-klormetylisoksazol er kjent fra litteraturen og kan fremstilles ved fremgangsmåten ifølge G. Stagno . d'Alcontres og G. Gurrocres, Atti soc. peloritana sei. fis. mat. nat. 3, 179-86 (1956/57), [CA 52, 1994 c] fra acetonitriloksyd og propargylklorid. The compound 3-methyl-5-chloromethylisoxazole is known from the literature and can be prepared by the method according to G. Stagno. d'Alcontres and G. Gurrocres, Atti soc. Peloritana said. fart food. night 3, 179-86 (1956/57), [CA 52, 1994 c] from acetonitrile oxide and propargyl chloride.
2- (2-dimetylaminoetoksy)benzaldehyd (k.p.QQ5 = 110°C) fremstilles av salicylaldehyd og dimetylaminoetylklorid i klorbenzen i nærvær av kaliummetylat. 2-(2-dimethylaminoethoxy)benzaldehyde (b.p.QQ5 = 110°C) is prepared from salicylaldehyde and dimethylaminoethyl chloride in chlorobenzene in the presence of potassium methylate.
Analogt med fremgangsmåten beskrevet i eksempel 8, ble Analogous to the method described in example 8, was
de følgende forbindelser (eksempel 9-23) fremstilt: the following compounds (Example 9-23) prepared:
Eksempel 9 Example 9
5-[o-(2-dimetylamino)etoksy]styryl-3-fenyl-isoksazol-hydroklorid fremstilles fra (3-fenyl-isoksazolyl-5-)-metylfosfon-syre-dietylester og 2-(2-dimetylamino)etoksybenzaldehyd i et utbytte på 23,4% av det teoretiske med et smeltepunkt på 189-190°C. 5-[o-(2-dimethylamino)ethoxy]styryl-3-phenyl-isoxazole hydrochloride is prepared from (3-phenyl-isoxazolyl-5-)-methylphosphonic acid diethyl ester and 2-(2-dimethylamino)ethoxybenzaldehyde in a yield of 23.4% of the theoretical with a melting point of 189-190°C.
Den som utgangsmateriale anvendte fosfonester fremstilles fra 3-fenyl-5-brommetylisoksazol (H. G. Sen, D. Seth und U. N. Joshi, J. med. chem. 9, s. 431-33 (1966) og trietylfosfit i form The phosphon ester used as starting material is prepared from 3-phenyl-5-bromomethylisoxazole (H. G. Sen, D. Seth und U. N. Joshi, J. med. chem. 9, p. 431-33 (1966)) and triethyl phosphite in the form
av en gul, ikke-destillerbar olje. Utbytte: kvantitativt. of a yellow, non-distillable oil. Yield: quantitative.
Eksempel 10 Example 10
5-[o-(2-dimetylamino)-etoksy]styryl-3-metyl-oksadiazol-(l,2,4)-hydroklorid fremstilles fra (3-metyloksadiazolyl-(1,2,4)-5)-metylfosfonsyredietylester og 2-(2-dimetylamino)etoksybenzaldehyd i form av fargeløse krystaller med smeltepunkt 186-188 C. Utbytte: 55% av det teoretiske. 5-[o-(2-dimethylamino)-ethoxy]styryl-3-methyl-oxadiazole-(1,2,4)-hydrochloride is prepared from (3-methyloxadiazolyl-(1,2,4)-5)-methylphosphonic acid diethyl ester and 2-(2-dimethylamino)ethoxybenzaldehyde in the form of colorless crystals with a melting point of 186-188 C. Yield: 55% of the theoretical.
Den som utgangsmateriale anvendte fosfonester fremstilles fra 3-metyl-5-klormetyloksadiazol-(l,2,4) og trietylfosfit som en gulig olje med k.p. 110-112°C ved 0,2 mm Hg. Utbytte: 48,5% av det teoretiske. The phosphon ester used as starting material is prepared from 3-methyl-5-chloromethyloxadiazole-(1,2,4) and triethyl phosphite as a yellow oil with b.p. 110-112°C at 0.2 mm Hg. Yield: 48.5% of the theoretical.
3- metyl-5-klormetyloksadiazol-(l,2,4) er kjent fra litteraturen (Fransk patent 363.235, CA 62, s. 5282 b), og kan 3-methyl-5-chloromethyloxadiazole-(1,2,4) is known from the literature (French patent 363,235, CA 62, p. 5282 b), and can
fremstilles fra acetamidoksim og kloracetylklorid. is produced from acetamidoxime and chloroacetyl chloride.
Eksempel 11 Example 11
Av l-metyl-benzimidazolyl-2-metanfosfonsyredietylester (sm.p. = 75,5 - 76,5°C) og 2-(2-dimetylaminoetoksy)benzaldehyd (k.p.Q Q5 = 110°C) fremstilles 2- 12-(2-dimetylaminoetoksy)styryl]-1-metylbenzimidazol-dihydroklorid med sm.p. 208°C med et utbytte på 45%. From 1-methyl-benzimidazolyl-2-methanephosphonic acid diethyl ester (m.p. = 75.5 - 76.5°C) and 2-(2-dimethylaminoethoxy)benzaldehyde (b.p.Q Q5 = 110°C) 2- 12-(2 -dimethylaminoethoxy)styryl]-1-methylbenzimidazole dihydrochloride with m.p. 208°C with a yield of 45%.
Eksempel 12 Example 12
Av l-fenyl-6-klor-benzimidazolyl-2-metanfosfonsyredietylester (sm.p. 140°C; hydroklorid) og 2-(2-dimetylaminoetoksy-benzaldehyd (k.p.00^ = 110°C) fremstilles 2-[2-(2-dimetylamino-etoksy) styryl] -l-fenyl-6-klor-benzimidazol-dihydroklorid (sm.p. 256 C, Utbytte: 40%). 2-[2-( 2-dimethylamino-ethoxy)styryl]-1-phenyl-6-chloro-benzimidazole dihydrochloride (m.p. 256 C, Yield: 40%).
Eksempel 13 Example 13
Av l-metyl-6-klor-benzimidazolyl-2-metanfosfonsyredietyl-estér (sm.p. 103-106°C) og 2-(2-dimetylaminoetoksy)azetofenon (k.p.QQg = 103-105°C) fremstilles 1-(l-metyl-6-klor-benzimidazolyl-(2))-2-(2-dimetylaminoetoksyfenyl)-propen-dihydroklorid (sm.p. 121°C, Utbytte: 55% av det teoretiske). From 1-methyl-6-chloro-benzimidazolyl-2-methanephosphonic acid diethyl ester (m.p. 103-106°C) and 2-(2-dimethylaminoethoxy)azetophenone (b.p. QQg = 103-105°C) is prepared 1-( 1-methyl-6-chloro-benzimidazolyl-(2))-2-(2-dimethylaminoethoxyphenyl)-propene dihydrochloride (m.p. 121°C, Yield: 55% of theory).
Eksempel 14 Example 14
Av 1-fenyl-5-trifiuormetyl-benzimidazolyl-2-metanfosfonsyredietylester (k.pvQ.13=189°C) og 2-(2-dimetylaminoetoksy)-benzaldehyd (k.p.Q 05=110°C) fremstilles 2-[2-(2-dimetylaminoetoksy)-styryl]-l-fenyl-5-trifluormetyl-benzimidazol (sm.p. 225°C; 2-[2-( 2-dimethylaminoethoxy)-styryl]-1-phenyl-5-trifluoromethyl-benzimidazole (m.p. 225°C;
Utbytte: 50% av det teoretiske. Yield: 50% of the theoretical.
Eksempel 15 Example 15
Av pyridyl-27:metanfosfonsyredietylester (k.p.Q 02=H8oC) ~ og 2-(2-dimetylaminoetoksy)-acetofenon (k.p.Q Q5 = 103-105°C) fremstilles 1-(2-pyridyl)-2-(2-dimetylaminoetoksyfenyl)-propen-1. From pyridyl-27:methanephosphonic acid diethyl ester (b.p.Q 02=H8oC) ~ and 2-(2-dimethylaminoethoxy)-acetophenone (b.p.Q Q5 = 103-105°C) 1-(2-pyridyl)-2-(2-dimethylaminoethoxyphenyl)- propene-1.
Ved fremstillingen av dihydrokloridet får man i krystal-liserende form trans^isoméren (sm.p. 196-198°C) fra aceton. I et tynnsjiktkromatogram ; (aceton/etylacetat = 1:1 på basisk aluminiumoksyd, sprøytereagens: Dragendorffs reagens) har forbindelsen en Rf=0,85. Moderluten fra fremstillingen av trans-isomeren inndampes, residuet oppløses i vann, tilsettes natronlut, 6g basen ekstraheres med eter. Etter inndampning av eterekstrakten destilleres fraksjonert. Man får cis-forbindelsen som en gulaktig-fargeløs olje (k.p. 007= 122-135°C) som i tynnsjiktkromatogram In the preparation of the dihydrochloride, the trans-isomer (m.p. 196-198°C) is obtained in crystalline form from acetone. In a thin-layer chromatogram; (acetone/ethyl acetate = 1:1 on basic aluminum oxide, spray reagent: Dragendorff's reagent) the compound has an Rf=0.85. The mother liquor from the preparation of the trans-isomer is evaporated, the residue is dissolved in water, caustic soda is added, 6g of the base is extracted with ether. After evaporation of the ether extract, it is fractionally distilled. The cis compound is obtained as a yellowish-colourless oil (b.p. 007= 122-135°C) as in thin-layer chromatogram
viser en lavere Rf-verdi (0,80) enn trans-forbindelsen. shows a lower Rf value (0.80) than the trans compound.
Eksempel 16 Example 16
Av pyridyl-2-metanfosfonsyredietylester (k.p._ n,= 118°C) Of pyridyl-2-methanephosphonic acid diethyl ester (b.p._ n,= 118°C)
0,03 0.03
og 2-(3-dimetylaminopropoksy)acetofenon (k.p.Q 4=130 C) fremstilles 1- (2-pyridyl)- 2- 12-(3-dimetylaminopropoksy)-fenylj-propen-l-dihydroklorid i trans-form, analogt med trans-forbindelsen i eksempel 15 (sm.p. = 196-197°C). Fra moderluten etter hydroklorid-krystallisasjonen isoleres cis-forbindelsen som en fargeløs olje (k.p.0 16= 143°C) I tynnsjiktkromatogram adskiller begge forbindelsene se? tydelig. Trans-forbindelse: R^= 0, "cis-forTanaTélse: R,. = 0,65 (Elueringsmiddel:■ aceton/etylacetat = 1:1 på tynnsjikt-plater av basisk aluminiumoksyd, sprøytereagens: Dragendorffs reagens). and 2-(3-dimethylaminopropoxy)acetophenone (b.p.Q 4=130 C) is prepared 1-(2-pyridyl)-2- 12-(3-dimethylaminopropoxy)-phenylj-propene-1-dihydrochloride in trans form, analogously to trans - the compound in example 15 (m.p. = 196-197°C). From the mother liquor after the hydrochloride crystallization, the cis-compound is isolated as a colorless oil (b.p.0 16= 143°C). In a thin-layer chromatogram, both compounds separate see? clearly. Trans-compound: R^= 0, "cis-forTanaTélse: R,. = 0.65 (Eluent: ■ acetone/ethyl acetate = 1:1 on thin-layer plates of basic alumina, spray reagent: Dragendorff's reagent).
Eksempel 17 Example 17
Av pyridyl-2-metanfosfonsyredietylester (k.p.Q 03=118°C) og 2- (3-dimetylaminopropoksy)-benzaldehyd fremstilles 2-[2-(3-dimetyl-aminopropoksy) styryl] pyridin i form av et glass-aktig, sprøtt dihydroklorid i et utbytte på 36% av det teoretiske. From pyridyl-2-methanephosphonic acid diethyl ester (b.p.Q 03=118°C) and 2-(3-dimethylaminopropoxy)-benzaldehyde, 2-[2-(3-dimethylaminopropoxy)styryl]pyridine is prepared in the form of a glassy, brittle dihydrochloride in a yield of 36% of the theoretical.
Eksempel 18 Example 18
Av l-metyl-6-klorbenzimidazolyl-2-metanfosfonsyredietylester (sm.p. 103-106°C) og 2-(3-dimetylaminopropoksy)-acetofenon (k.p.n .-130°C) fremstilles 1-(l-metyl-6-klor-benzimidazolyl-2)-2-(3-dimetylaminopropoksyfenyl)-propen-l-dihydroklorid. (sm.p. 211 oC; Utbytte: 48% av det teoretiske). 1-(l-Methyl-6 -chloro-benzimidazolyl-2)-2-(3-dimethylaminopropoxyphenyl)-propene-1-dihydrochloride. (m.p. 211 oC; Yield: 48% of the theoretical).
Eksempel 19 Example 19
Av benzylfosfonsyredietylester (k.p.^=148°C) og 2-(2-dimetylaminoetoksy) benzaldehyd (k.p.n ' _=11.0 C) fremstiolles 2-(2-dimetylaminoetoksy)-stilben-hydroklorid (sm.p. 199 C; From benzylphosphonic acid diethyl ester (b.p.^=148°C) and 2-(2-dimethylaminoethoxy)benzaldehyde (b.p.n ' _=11.0 C) 2-(2-dimethylaminoethoxy)-stilbene hydrochloride (m.p. 199 C) is prepared;
Utbytte: 58% av det teoretiske). Yield: 58% of the theoretical).
Eksempel 20 Example 20
Av pyridyl-2-metanfosfonsyredietylester (k.p.Q 02=118°C) Of pyridyl-2-methanephosphonic acid diethyl ester (b.p.Q 02=118°C)
og 2-(2-dietylaminoetoksy)benzaldehyd (k.p.Q 05=110°C) fremstilles 2- 12-(2-dietylaminoetoksy)styryl]pyridin-dihydroklorid (sm.p. 198°C; Utbytte: 20% av det teoretiske). and 2-(2-diethylaminoethoxy)benzaldehyde (b.p.Q 05=110°C) 2-12-(2-diethylaminoethoxy)styryl]pyridine dihydrochloride is prepared (m.p. 198°C; Yield: 20% of the theoretical).
Eksempel 21 Example 21
Av pyridyl-2-metanfosfonsyredietylester (k.p.Q 03=118°C) og 2-(2-dimetylaminoetoksy)4-metoksy-benzaldehyd (k.p.Q 03=121-125 C) fremstilles 2- 12-(2-dimetylaminoetoksy-4-metoksy)styryl]-pyridin- From pyridyl-2-methanephosphonic acid diethyl ester (b.p.Q 03=118°C) and 2-(2-dimethylaminoethoxy)4-methoxy-benzaldehyde (b.p.Q 03=121-125 C) 2- 12-(2-dimethylaminoethoxy-4-methoxy) is prepared styryl]-pyridine-
dihydroklorid (sm.p. 221°C; Utbytte: 31% av det teoretiske). dihydrochloride (m.p. 221°C; Yield: 31% of theory).
Eksempel 22 Example 22
Av 2-pyridyl-metanfosfonsyredietylester (k.p.Q 05=118°C) og 2-(2-dimetylaminoetoksy)benzaldehyd (k.p.Q 05=110°C) fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-pyridin-monohydroklorid (sm.p. 183°C; Utbytte: 43% av det teoretiske). • 2-[2-(2-dimethylaminoethoxy)styryl]-pyridine monohydrochloride (sm .p. 183°C; Yield: 43% of the theoretical). •
Eksempel 23 Example 23
Av 2-kinolylmetanfosfonsyredietylester (k.p. =138- Of 2-quinolylmethanephosphonic acid diethyl ester (b.p. =138-
O ' 035 O'035
145 C) og 2-(2-dimetylaminoetoksybenzaldehyd (k.p. ,=110 C) 145 C) and 2-(2-dimethylaminoethoxybenzaldehyde (b.p. = 110 C)
U z UD U z UD
fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]-kinolin-monohydro-klorid (sm.p. 188°C; Utbytte: 77% av det teoretiske). 2-[2-(2-dimethylaminoethoxy)styryl]-quinoline monohydrochloride is prepared (m.p. 188°C; Yield: 77% of theory).
Eksempel 24 Example 24
I 50 ml absolutt dioksan suspenderer man 2,0 g natrium- In 50 ml of absolute dioxane, suspend 2.0 g of sodium
hydrid og tilsetter dråpevis under god omrøring i løpet av 15 hydride and add dropwise with good stirring during 15
minutter ved 28°C en oppløsning av 6,3 g 2-(2-dimetylaminoetoksy)-benzylfosfonsyredietylester, og man iakttar en middels hydrogenutvikling. Man omrører videre i 1 time og tilsetter deretter dråpevis i løpet av 15 minutter en oppløsning av 2,14 g pyridin-3-aldehyd i 20 ml absolutt dioksan, hvorved man igjen kan iaktta gassutvikling. Etter henstand natten over spalter man med is og ekstraherer reaksjonsproduktet med kloroform. Etter avdestillering av oppløsningsmidlet blir det tilbake en lysebrun olje. Man opp-løser den i etanol og utfeller hydrokloridet med eterisk saltsyre, minutes at 28°C a solution of 6.3 g of 2-(2-dimethylaminoethoxy)-benzylphosphonic acid diethyl ester, and moderate hydrogen evolution is observed. Stirring continues for 1 hour and then a solution of 2.14 g of pyridine-3-aldehyde in 20 ml of absolute dioxane is added dropwise over 15 minutes, whereby gas evolution can again be observed. After standing overnight, the mixture is split with ice and the reaction product is extracted with chloroform. After distilling off the solvent, a light brown oil remains. It is dissolved in ethanol and the hydrochloride is precipitated with ethereal hydrochloric acid,
og hydrokloridet omkrystalliseres fra etanol under anvendelse av benkull. Man får 3,0 g (svarende til 44% av det teoretiske) 3|-[ 2-(2-dimetylaminoetoksy) styrylJpyridin-dihydroklorid i form av lysegule krystaller med smeltepunkt 238°C. Forbindelsen er ensartet i tynnsjiktkromatogram (basisk aluminiumoksyd (Merck); Elueringsmiddel: etylacetat; Sprøytereagens: Dragendorffs reagens) and the hydrochloride is recrystallized from ethanol using bone charcoal. 3.0 g (corresponding to 44% of the theoretical) 3|-[ 2-(2-dimethylaminoethoxy) styrylpyridine dihydrochloride is obtained in the form of pale yellow crystals with a melting point of 238°C. The compound is uniform in thin-layer chromatogram (basic alumina (Merck); Eluent: ethyl acetate; Syringe reagent: Dragendorff's reagent)
(Rf = 0,75). (Rf = 0.75).
Den som utgangsmateriale anvendte 2-(2-dimetylaminoetoksy)-benzylfosfonsyredietylester fremstilles som følger: 2-(2-dimetylaminoetoksy)benzaldehyd reduseres med natrium- • borhydrid i metanol i 77%ig utbytte til 2-(2-dimetylaminoetoksy)-benzylalkohol (k.p._ ,=125°C), og denne omsettes med tionylklorid til 2-(2-dimetylamino» etoksy)benzylklorid-hydroklorid (sm.p.=145-147 oC). Denne forbindelse omsettes i benzen med overskudd av dietylfosfit-natrium til 2-(2-dimetylaminoetoksy)benzylfosfonsyredietylester (<k>.<p.>o8 = 140-148°C). The 2-(2-dimethylaminoethoxy)-benzylphosphonic acid diethyl ester used as starting material is prepared as follows: 2-(2-dimethylaminoethoxy)benzaldehyde is reduced with sodium • borohydride in methanol in 77% yield to 2-(2-dimethylaminoethoxy)-benzyl alcohol (b.p. _ ,=125°C), and this is reacted with thionyl chloride to 2-(2-dimethylamino»ethoxy)benzyl chloride hydrochloride (m.p.=145-147 oC). This compound is reacted in benzene with an excess of sodium diethylphosphite to 2-(2-dimethylaminoethoxy)benzylphosphonic acid diethyl ester (<k>.<p.>o8 = 140-148°C).
Analogt med fremgangsmåten beskrevet i eksempel 24 fremstilles de følgende forbindelser (eksempel 25-30): Analogous to the method described in example 24, the following compounds are prepared (examples 25-30):
Eksempel 25 Example 25
Av 2-(2-dimetylaminoetoksy)-benzylfosfonsyredietylester (k.p.0 8=140-148°C) og furfurol fremstiller man 2-[2-(2-dimetyl-aminoetoksy) styryl1 furan-hydroklorid (sm.p. 156-158°C) Utbytte: From 2-(2-dimethylaminoethoxy)-benzylphosphonic acid diethyl ester (b.p.0 8=140-148°C) and furfurol, 2-[2-(2-dimethylaminoethoxy)styryl-1 furan hydrochloride (m.p. 156-158°) is prepared C) Dividend:
22% av det teoretiske. 22% of the theoretical.
Eksempel 26 Example 26
Av 2-(2-dimetylaminoetoksy)-benzylfosfonsyredietylester (k.p.Q 8=140-148°C) og tiofen-2-aldehyd fremstiller man 2-[2-(2-dimetylaminoetoksy)styryl]tiofen-hydroklorid (sm.p. 187-188°C; From 2-(2-dimethylaminoethoxy)-benzylphosphonic acid diethyl ester (b.p.Q 8=140-148°C) and thiophene-2-aldehyde, 2-[2-(2-dimethylaminoethoxy)styryl]thiophene hydrochloride (m.p. 187- 188°C;
Utbytte: 60% av det teoretiske). Yield: 60% of the theoretical).
Eksempel 27 Example 27
Av 2-(2-dimetylaminoetoksy)^-benzylfosfonsyredietylester (k.p.Q 8=140-148°C) og 2,7-nafthyridin-4-aldehyd [Ch. Jutz et al. From 2-(2-dimethylaminoethoxy)^-benzylphosphonic acid diethyl ester (b.p.Q 8=140-148°C) and 2,7-naphthyridine-4-aldehyde [Ch. Jutz et al.
Ber. 99, 2479-2490 (1966)] fremstilles 4-[2-(2-dimetylaminoetoksy)-styryl]-2,7Hiafthyridin-dihydroklorid (sm.p. 197°C; Utbytte: 24% av det teoretiske). Pray. 99, 2479-2490 (1966)], 4-[2-(2-dimethylaminoethoxy)-styryl]-2,7Hyaphthyridine dihydrochloride (m.p. 197°C; Yield: 24% of theory) is prepared.
Eksempel 28 Example 28
Av 2-(2-dimetylaminoetoksy)benzylfosfonsyredietylester (k.p.Q 8=140-148°C) og pyridin-2-aldehyd fremstilles 2-[2-(2-dimetylaminoetoksy)styryl]pyridin-monohydroklorid (sm.p.=183 C; Utbytte: 52% av det teoretiske). From 2-(2-dimethylaminoethoxy)benzylphosphonic acid diethyl ester (b.p.Q 8=140-148°C) and pyridine-2-aldehyde is prepared 2-[2-(2-dimethylaminoethoxy)styryl]pyridine monohydrochloride (m.p.=183 C; Yield: 52% of the theoretical).
Eksempel 29 Example 29
Av 2-(2-dimetylaminoetoksy)benzylfosfonsyredietylester (k.p._ o=140-148°C) og kinolin-2-aldehyd fremstilles 2-12-(2- 2-12-(2-
°'° o dimetylaminoetoksy)styryl]kinolin-monohydroklorid (sm.p. 188 C; Utbytte: 48% av det teoretiske). °'° o dimethylaminoethoxy)styryl]quinoline monohydrochloride (m.p. 188 C; Yield: 48% of the theoretical).
Eksempel 30 Example 30
Av 2-(2-dimetylaminoetoksy)benzylfosfonsyredietylester (k.p._ q=140-148°C) og benzaldehyd fremstilles 2-(2-dimetylamino-etoksy)' stilben-hydroklorid (sm.p. = 199 oC; Utbytte: 61% av det teoretiske). From 2-(2-dimethylaminoethoxy)benzylphosphonic acid diethyl ester (bp.q=140-148°C) and benzaldehyde, 2-(2-dimethylaminoethoxy)' stilbene hydrochloride (m.p. = 199 oC; Yield: 61% of the theoretical).
Eksempel 31 Example 31
En oppløsning av 400 g 2-(2-acetoksy-styryl)pyridin i A solution of 400 g of 2-(2-acetoxy-styryl)pyridine i
1250 ml klorbenzen tilsettes 235,5 g kaliummetylat og oppvarmes til 110°C under omrøring, hvorved det dannes en gul suspensjon. 483 g dimetylaminoetylklorid-hydroklorid ristes i en ristetrakt sammen 1250 ml of chlorobenzene is added to 235.5 g of potassium methylate and heated to 110°C with stirring, whereby a yellow suspension is formed. 483 g of dimethylaminoethyl chloride hydrochloride are shaken together in a shaking funnel
med 100 ml iskald 30%ig natronlut, og den frigjorte, oljeaktige base fraskilles og dryppes inn i suspensjonen i 6 like porsjoner i løpet av 15 minutter (den mengde dimetylaminoetylklorid som ikke benyttes, oppbevares ved 0°C for å forhindre fortidlig egenreaksjon). Man omrører i ytterligere 30 minutter ved 110°C, avkjøler deretter with 100 ml of ice-cold 30% caustic soda, and the released, oily base is separated and dripped into the suspension in 6 equal portions over the course of 15 minutes (the amount of dimethylaminoethyl chloride that is not used is stored at 0°C to prevent premature self-reaction). The mixture is stirred for a further 30 minutes at 110°C, then cooled
og tilsetter is. Etter ekstrahering med eter, tørring med vann- and add ice. After extraction with ether, drying with water-
fritt natriumsulfat og avdampning av oppløsnihgsmidlet blir det tilbake en olje som destilleres i vakuum; k.p.„ rt,=156-161°C. free sodium sulfate and evaporation of the solvent leaves an oil which is distilled in vacuum; b.p.„ rt,=156-161°C.
O, Ob O, Ob
Man får 376 g av en honningfarget olje (utbytte: 83,9% av det teoretiske). You get 376 g of a honey-coloured oil (yield: 83.9% of the theoretical).
123 g av det oljeaktige reaksjonsprodukt oppløses i en blanding av 750 ml etylacetat og 330 ml absolutt etanol. Hertil tilsetter man under god omrøring gradvis 430 ml av en oppløsning av 132 ml etanolisk saltsyre (12,72%ig vekt/volum) i 638 ml etylacetat, 123 g of the oily reaction product are dissolved in a mixture of 750 ml of ethyl acetate and 330 ml of absolute ethanol. To this, with good stirring, gradually add 430 ml of a solution of 132 ml of ethanolic hydrochloric acid (12.72% weight/volume) in 638 ml of ethyl acetate,
og ingen gulfarging bør opptre. Deretter tilsetter man 600 ml etylacetat og avkjøler til 0°C. De utskilte krystaller av 2- 12-(2-dimetylaminoetoksy)styryl]pyridin-monohydroklorid avsuges, vaskes med etylacetat og tørres i en eksikator over konsentrert svovelsyre og kaliumhydroksyd. Smeltepunkt: 186-187,5°C; and no yellowing should occur. 600 ml of ethyl acetate are then added and cooled to 0°C. The separated crystals of 2-12-(2-dimethylaminoethoxy)styryl]pyridine monohydrochloride are filtered off with suction, washed with ethyl acetate and dried in a desiccator over concentrated sulfuric acid and potassium hydroxide. Melting point: 186-187.5°C;
Utbytte ved denne saltdannelse: 93 g. Yield by this salt formation: 93 g.
Hvis man anvender et overskudd av etanolisk saltsyre, If an excess of ethanolic hydrochloric acid is used,
ialt 300 ml av saltsyren med den ovenfor angitte konsentrasjonen, farges oppløsningen dypt gul, og man isolerer dihydrokloridet av 2-[2-(2-dimetylaminoetoksy)styryl]pyridin med smeltepunkt 218-220°C. For fremstilling av p-toluensulfonatet oppløser man 2,68 g av den a total of 300 ml of the hydrochloric acid with the concentration indicated above, the solution is colored deep yellow, and the dihydrochloride of 2-[2-(2-dimethylaminoethoxy)styryl]pyridine with a melting point of 218-220°C is isolated. To prepare the p-toluenesulfonate, 2.68 g of it is dissolved
frie base av 2-/2-(2-dimetylaminoetoksy)styryl]pyridin i 20 ml absolutt etylacetat og tilsetter under omrøring langsomt 19 ml av en oppløsning av 1,72 g p-toluensulfonsyre i 20 ml etylacetat. Etter avkjøling i is utkrystalliserer mono-p-toluensulfonatet, som vaskes med litt etylacetat og tørres i eksikator over svovelsyre. Smeltepunkt: 128-130°C; Utbytte: 3,1 g. free base of 2-(2-(2-dimethylaminoethoxy)styryl]pyridine in 20 ml of absolute ethyl acetate and slowly add, with stirring, 19 ml of a solution of 1.72 g of p-toluenesulfonic acid in 20 ml of ethyl acetate. After cooling in ice, the mono-p-toluenesulfonate crystallizes out, which is washed with a little ethyl acetate and dried in a desiccator over sulfuric acid. Melting point: 128-130°C; Yield: 3.1 g.
For fremstilling av det fosforsyresalt oppløser man 2,68 g To prepare the phosphoric acid salt, 2.68 g is dissolved
av den frie base av 2-[2-(2-dimetylaminoetoksy)styrylIpyridin i 40 ml etanol og tilsetter langsomt dråpevis under omrøring en opp-løsning av 0,346 g 85%ig fosforsyre. Den fargeløse oppløsning inndampes til 25 ml, tilsettes 25 ml etylacetat og anbringes i et of the free base of 2-[2-(2-dimethylaminoethoxy)styrylpyridine in 40 ml of ethanol and slowly adding a solution of 0.346 g of 85% phosphoric acid dropwise while stirring. The colorless solution is evaporated to 25 ml, 25 ml of ethyl acetate is added and placed in a
isbad. Etter 1 time utkrystalliseres et hvitt bunnfall av fosfatet ice bath. After 1 hour, a white precipitate of the phosphate crystallizes out
av den ovennevnte base. I henhold til analysen kommer det på of the above base. According to the analysis, it comes on
1 mol base 1/3 mol fosforsyre. Smeltepunkt: 133-134°C; 1 mol base 1/3 mol phosphoric acid. Melting point: 133-134°C;
Utbytte: 1,1 g Yield: 1.1 g
Det som utgangsmateriale anvendte 2-(2-acetoksy-styryl)-pyridin (k.p.Q(06=162-175°C) ble fremstilt av 2-pikolin og salicylaldehyd i nærvær av eddiksyreanhydrid ved 170°C. The starting material 2-(2-acetoxy-styryl)-pyridine (b.p.Q(06=162-175°C)) was prepared from 2-picoline and salicylaldehyde in the presence of acetic anhydride at 170°C.
Analogt med fremgangsmåten beskrevet i eksempel 31 Analogous to the procedure described in example 31
fremstilles også de følgende forbindelser (eksempel 32-34). the following compounds are also prepared (examples 32-34).
Eksempel 32 Example 32
Av l-(2-acetoksyfenyl)-2-(pyridyl-2)-propen-l (k.p.Q 05=140°C) og dimetylaminoetylklorid fremstilles 1-(2-dimetylaminoetoksyfenyl)-2-(pyridyl-2)-propen-l-monohydroklorid. Sm.p. = 128-133°C; From 1-(2-acetoxyphenyl)-2-(pyridyl-2)-propene-1 (b.p.Q 05=140°C) and dimethylaminoethyl chloride, 1-(2-dimethylaminoethoxyphenyl)-2-(pyridyl-2)-propene-1 is prepared -monohydrochloride. Sm.p. = 128-133°C;
utbytte: 85% av det teoretiske. yield: 85% of the theoretical.
Eksempel 33 Example 33
Av 2-(2-acetoksystyryl)pyridin (k.p.Q 06=162-175°C) og 2-klor-N,N-dimetylpropylamin fremstilles 2-[2-(3-dimetylaminoprop-2-oksy)-styryl]pyridin. (k.p.Q 025=158-159°C; utbytte: 86% av det teoretiske). From 2-(2-acetoxystyryl)pyridine (b.p.Q 06=162-175°C) and 2-chloro-N,N-dimethylpropylamine, 2-[2-(3-dimethylaminoprop-2-oxy)-styryl]pyridine is prepared. (b.p. Q 025=158-159°C; yield: 86% of the theoretical).
Eksempel 34 Example 34
Av 2-(2-hydroksystyryl)kinolin (sm.p.=274-278°C) og dimetylaminoetylklorid fremstilles 2-[2-(2-dimetylaminoetoksy)styryll-kinolin-monohydroklorid (sm.p. =188°C; utbytte: 86% av det teoretiske) From 2-(2-hydroxystyryl)quinoline (m.p.=274-278°C) and dimethylaminoethyl chloride, 2-[2-(2-dimethylaminoethoxy)styryl-quinoline monohydrochloride (m.p.=188°C; yield) is prepared : 86% of the theoretical)
Eksempel 35 Example 35
16 g 2- 12-(2-kloretoksy)styryl]pyridin (sm.p.=57-59°C) 16 g 2-12-(2-chloroethoxy)styryl]pyridine (m.p.=57-59°C)
oppløses i 50 ml metanol og blandes ved -15°C med 120 ml frisk, flytende metylamin fra en bombe og oppvarmes i autoklav i 4 timer ved 80°C. Etter avkjøling og avspenning inndampes autoklav-innholdet, residuet oppløses i fortynnet eddiksyre og ristes to ganger med eter for å fjerne de svakt basiske produkter. Deretter gjøres blandingen alkalisk under avkjøling med 2N natronlut, og reaksjonsproduktet ekstraheres med etylacetat. Etter tørring med natriumsulfat blir det tilbake etter avdestillering et oljeaktig residuum som ved henstand natten over krystalliserer (13,8 g, dissolve in 50 ml of methanol and mix at -15°C with 120 ml of fresh, liquid methylamine from a bomb and heat in an autoclave for 4 hours at 80°C. After cooling and relaxation, the autoclave contents are evaporated, the residue is dissolved in dilute acetic acid and shaken twice with ether to remove the weakly basic products. The mixture is then made alkaline while cooling with 2N caustic soda, and the reaction product is extracted with ethyl acetate. After drying with sodium sulphate, an oily residue remains after distillation, which crystallizes on standing overnight (13.8 g,
svarende til 88,2% av det teoretiske). Forbindelsen oppløses i 200 ml aceton, filtreres med aktivt kull og tilsettes 20 ml etanol. corresponding to 88.2% of the theoretical). The compound is dissolved in 200 ml of acetone, filtered with activated carbon and 20 ml of ethanol is added.
Til denne blanding setter man forsiktig en oppløsning av 15,3 ml etanolisk 12,72%ig saltsyre (vekt/volum) i 50 ml aceton til en begynnende gulfarging, og til dette er det nødvendig med ca. 59 ml av den sure felleoppløsning. Man tilsetter deretter eter til begynnende uklarhet og omrører i isbad under avkjøling. I løpet av 1 time utkrystalliserer et mattgult stoff som avsuges og tørres i eksikator. Man får 9,3 g (svarende til 52% av det teoretiske) 2- 12-(2-metylaminoetoksy)styryl]pyridin-monohydroklorid med smeltepunkt 178-180°C. To this mixture, carefully add a solution of 15.3 ml of ethanolic 12.72% hydrochloric acid (weight/volume) in 50 ml of acetone until it begins to turn yellow, and for this you need approx. 59 ml of the acidic trap solution. Ether is then added until it begins to cloud and stirred in an ice bath while cooling. Within 1 hour, a dull yellow substance crystallizes out, which is suctioned off and dried in a desiccator. 9.3 g (corresponding to 52% of the theoretical) of 2-12-(2-methylaminoethoxy)styryl]pyridine monohydrochloride with a melting point of 178-180°C are obtained.
Det som utgangsmateriale anvendte 2- 12-(2-kloretoksy)-styryl]pyridin(sm.p. = 57-59°C fremstilles av 2-(2-acetoksystyryl)-pyridin (se eks. 32) og benzensulfonsyre-2-kloretylester i nærvær av kaliummetylat i toluen. The 2-12-(2-chloroethoxy)-styryl]pyridine (m.p. = 57-59°C) used as starting material is prepared from 2-(2-acetoxystyryl)-pyridine (see ex. 32) and benzenesulfonic acid-2- chloroethyl ester in the presence of potassium methylate in toluene.
Analogt med fremgangsmåten beskrevet i eksempel 35 fremstilles også de følgende forbindelser (eksempel 36-48): Analogous to the method described in example 35, the following compounds are also prepared (examples 36-48):
Eksempel 36 Example 36
Av 2- 12-(2-kloretoksy)styryl]pyridin (sm.p.=57-59°C) og ammoniakk fremstilles 2-[2-(2-aminoetoksy)styrylIpyridin-dihydroklorid (sm.p. 269°C; utbytte: 49% av det teoretiske). From 2-12-(2-chloroethoxy)styryl]pyridine (m.p.=57-59°C) and ammonia, 2-[2-(2-aminoethoxy)styryl]pyridine dihydrochloride (m.p. 269°C) is prepared; yield: 49% of the theoretical).
Eksempel 37 Example 37
Av 2-t2-(2-kloretoksy)styryl]kinolin-hydroklorid (sm.p. 214-220°C) og metylamin fremstilles 2-[2-(2-metylaminoetoksy)styryl]-kinolin-monohydroklorid (sm.p. 170°C; Utbytte: 12,0% av det teoretiske. From 2-t2-(2-chloroethoxy)styryl]quinoline hydrochloride (m.p. 214-220°C) and methylamine, 2-[2-(2-methylaminoethoxy)styryl]-quinoline monohydrochloride (m.p. 170°C; Yield: 12.0% of the theoretical.
Eksempel 38 Example 38
Av 2- 12-(2-klor-etoksy)styryl]pyridin (sm.p. 57-58°C) og etylamin fremstilles 2- 12-(etylaminoetoksy)styryl]pyridin-dihydroklorid (sm.p. 211°C; utbytte: 48,3% av det teoretiske). From 2-12-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and ethylamine, 2-12-(ethylaminoethoxy)styryl]pyridine dihydrochloride (m.p. 211°C) is prepared; yield: 48.3% of the theoretical).
Eksempel 39 Example 39
Av 2-[2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og piperidin fremstilles 2- 12-(2-piperidinoetoksy)styryl]pyridin-dihydroklorid (sm.p. 176°C; utbytte: 31% av det teoretiske). From 2-[2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and piperidine, 2-12-(2-piperidinoethoxy)styryl]pyridine dihydrochloride (m.p. 176°C) is prepared ; yield: 31% of the theoretical).
Eksempel 40 Example 40
Av 2-[2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og morfolin fremstilles 2-[2-(2-morfolinoetoksy)styryl]pyridin-dihydroklorid (sm.p. 248°C; utbytte: 53% av det teoretiske). From 2-[2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and morpholine, 2-[2-(2-morpholinoethoxy)styryl]pyridine dihydrochloride (m.p. 248°) is prepared C; yield: 53% of the theoretical).
Eksempel 41 Example 41
Av 2-[2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og N-metylpiperazin fremstilles 2- 12-(2-metylpiperazinoetoksy)styryl]-pyridin-trihydroklorid (sm.p. 268°C; utbytte: 45% av det teoretiske). From 2-[2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and N-methylpiperazine, 2-12-(2-methylpiperazineethoxy)styryl]-pyridine trihydrochloride (m.p. 268°C; yield: 45% of the theoretical).
Eksempel 42 Example 42
Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og allylamin fremstilles 2- 12-(2-ailylaminoetoksy)styryl]pyridin-dihydroklorid (sm.p. 201°C; utbytte: 18% av det teoretiske). From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and allylamine, 2-12-(2-allylaminoethoxy)styryl]pyridine dihydrochloride (m.p. 201°C) is prepared; yield: 18% of the theoretical).
Eksempel 43 Example 43
Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og 2-f enyl et yl amin fremstilles 2-t 2-(2-/3-f enyletylaminoetoksy) styryl] - pyridin-dihydroklorid (sm.p. 263°C; utbytte: 54% av det teoretiske). From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and 2-phenylethylamine, 2-t2-(2-/3-phenylethylaminoethoxy)styryl]- pyridine dihydrochloride (m.p. 263°C; yield: 54% of theory).
Eksempel 44 Example 44
Av 2-[2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og 2-metoksyetylamin fremstilles 2-t 2- (2-/3-metoksyetylaminoetoksy) - styryl]-pyridin-monohydroklorid (sm.p. 147°C; utbytte: 45% av det teoretiske). From 2-[2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and 2-methoxyethylamine, 2-t 2-(2-/3-methoxyethylaminoethoxy)-styryl]-pyridine monohydrochloride is prepared (m.p. 147°C; yield: 45% of the theoretical).
Eksempel 45 Example 45
Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og di-(2-hydroksyetyl)amin fremstilles 2-t2-(2-dihydroksyetylamino-etoksy)styryl]pyridin-dihydroklorid (sm.p. 140°C; utbytte: 22% From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and di-(2-hydroxyethyl)amine, 2-t2-(2-dihydroxyethylaminoethoxy)styryl]pyridine dihydrochloride is prepared (m.p. 140°C; yield: 22%
av det teoretiske). of the theoretical).
Eksempel 46 Example 46
Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-58°C) og metyl-2-hydroksyetylamin fremstilles 2-[2-(2-N-metyl-N-hydroksy-etylaminoetoksy)styryl]pyridin-dihydroklorid (sm.p. 190°C; From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-58°C) and methyl-2-hydroxyethylamine, 2-[2-(2-N-methyl-N-hydroxy-ethylaminoethoxy)styryl is prepared ]pyridine dihydrochloride (m.p. 190°C;
utbytte: 42% av det teoretiske). yield: 42% of the theoretical).
Eksempel 47 Example 47
Av 2-t2-(2-kloretoksy)styryl]pyridin (sm.p. 57-59°C) og dimetylamin fremstilles 2-t 2-(2-dimetylaminoetoksy)styryl]pyridin-monohydroklorid (sm.p. 183°C; utbytte: 68% av det teoretiske). From 2-t2-(2-chloroethoxy)styryl]pyridine (m.p. 57-59°C) and dimethylamine, 2-t 2-(2-dimethylaminoethoxy)styryl]pyridine monohydrochloride (m.p. 183°C) is prepared ; yield: 68% of the theoretical).
Eksempel 48 Example 48
Av 2-t2-(2-kloretoksy)styryl]kinolin (sm.p. 214-220°C) og dimetylamin fremstilles 2-[2-(2-dimetylaminoetoksy)styrylJkinolin-monohydroklorid (sm.p. 188°C; utbytte: 74% av det teoretiske). From 2-t2-(2-chloroethoxy)styryl]quinoline (m.p. 214-220°C) and dimethylamine, 2-[2-(2-dimethylaminoethoxy)styryl]quinoline monohydrochloride (m.p. 188°C; yield) is prepared : 74% of the theoretical).
Eksempel 49 Example 49
24,5 g (3,5-dimetylisoksazolyl-4)-metyl-trifenyl-fosfoniumklorid i 150 ml absolutt etanol settes til 1,4 g natrium i 50 ml absolutt etanol. Til reaksjonsblandingen som er oppvarmet til 40°C, settes dråpevis under omrøring 7,8 g 2-(2-dimétylamino)-etoksybenzaldehyd, og deretter oppvarmes i 15 minutter til kokning. Etter avdampning av oppløsningsmidlet opptas reaksjonsblandingen 24.5 g of (3,5-dimethylisoxazolyl-4)-methyl-triphenyl-phosphonium chloride in 150 ml of absolute ethanol is added to 1.4 g of sodium in 50 ml of absolute ethanol. 7.8 g of 2-(2-dimethylamino)-ethoxybenzaldehyde are added dropwise with stirring to the reaction mixture which has been heated to 40°C, and then heated for 15 minutes until boiling. After evaporation of the solvent, the reaction mixture is taken up
i fortynnet saltsyre og ekstraheres med benzen for å fjerne det dannede trifenylfosfinoksyd. Den vandige fase gjøres alkalisk med 2N natronlut og ekstraheres flere ganger med eter. Det oljeaktige residuum som oppnås etter tørring med natriumsulfat og avdampning in dilute hydrochloric acid and extracted with benzene to remove the triphenylphosphine oxide formed. The aqueous phase is made alkaline with 2N caustic soda and extracted several times with ether. The oily residue obtained after drying with sodium sulphate and evaporation
av eteren, oppløses i aceton, og hydrokloridet felles med eterisk saltsyre. Etter to gangers omkrystallisering fra aceton får man 6 g (70% av det teoretiske) 4-[2-(2-dimetylamino)-etoksy-styryl]-3,4-dimetylisoksazol-hydroklorid som fargeløse krystaller med smeltepunkt 180-181°C. of the ether, dissolve in acetone, and the hydrochloride precipitate with ethereal hydrochloric acid. After two recrystallizations from acetone, 6 g (70% of the theoretical) of 4-[2-(2-dimethylamino)-ethoxy-styryl]-3,4-dimethylisoxazole hydrochloride are obtained as colorless crystals with a melting point of 180-181°C .
Det som utgangsmateriale anvendte fosfoniumklorid fremstilles av 3,5-dimetyl-4-klormetylisoksazol og trifenylfosfit med et utbytte på 89% av det teoretiske, i form av fargeløse krystaller. The phosphonium chloride used as starting material is prepared from 3,5-dimethyl-4-chloromethylisoxazole and triphenylphosphite with a yield of 89% of the theoretical, in the form of colorless crystals.
3,5-dimetyl-4-klormetylisoksazol kan fremstilles ifølge N.K. Kochetkov, E. D. Khomutova og M. V. Bazilevsky, J. Gen. Chem. (USSR) 28, 2736 (1958) ved klormetylering av 3,5-dimetyl-isoksazol. 3,5-dimethyl-4-chloromethylisoxazole can be prepared according to N.K. Kochetkov, E. D. Khomutova and M. V. Bazilevsky, J. Gen. Chem. (USSR) 28, 2736 (1958) by chloromethylation of 3,5-dimethylisoxazole.
Analogt med fremgangsmåten beskrevet i eksempel 49 fremstilles også de følgende forbindelser (eksempel 50-51): Analogous to the method described in example 49, the following compounds are also prepared (examples 50-51):
Eksempel 50 Example 50
Av benzylklorid og trifenylfosfin fremstilles benzyl-trifenylfosfoniumklorid [Wittig og SchSllkopf, Ber. 88, 1662 From benzyl chloride and triphenylphosphine, benzyl-triphenylphosphonium chloride is prepared [Wittig and Schlllkopf, Ber. 88, 1662
(1955)], og dette omsettes med 2-(dimetylaminoetoksy)benzaldehyd (k.p. ,=110°C) til 2-(dimetylaminoetoksy)stilben. Forbindelsen (1955)], and this is reacted with 2-(dimethylaminoethoxy)benzaldehyde (b.p.=110°C) to 2-(dimethylaminoethoxy)stilbene. The connection
0,05 o 0.05 o
isoleres som hydroklorid (sm.p. 199 C; utbytte: 73% av det teoretiske). is isolated as hydrochloride (m.p. 199 C; yield: 73% of the theoretical).
Eksempel 51 Example 51
Av 2-klor-metylpyridin (k.p.1=42-45°C) og trifenylfosfin fremstilles pikolyl-2-trifenylfosfoniumklorid og dette omsettes From 2-chloro-methylpyridine (b.p.1=42-45°C) and triphenylphosphine, picolyl-2-triphenylphosphonium chloride is prepared and this is reacted
med 2-(dimetylaminoetoksy)benzaldehyd (k.p.Q 05=110°C) til 2-[2-(2-dimetylaminoetoksy)styryl]pyridin, og dette isoleres som mono-hydrokloridet (sm.p. 186-187°C; utbytte: 66% av det teoretiske). with 2-(dimethylaminoethoxy)benzaldehyde (b.p.Q 05=110°C) to 2-[2-(2-dimethylaminoethoxy)styryl]pyridine, and this is isolated as the mono-hydrochloride (m.p. 186-187°C; yield: 66% of the theoretical).
Claims (2)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1939809A DE1939809B2 (en) | 1969-08-05 | 1969-08-05 | β-Aryl-2-aminoalkoxy-styrenes and process for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
NO135243B true NO135243B (en) | 1976-11-29 |
NO135243C NO135243C (en) | 1977-03-09 |
Family
ID=5741970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO3005/70A NO135243C (en) | 1969-08-05 | 1970-08-04 |
Country Status (25)
Country | Link |
---|---|
JP (6) | JPS4941433B1 (en) |
KR (1) | KR780000113B1 (en) |
AT (5) | AT302344B (en) |
BE (1) | BE754405A (en) |
BG (6) | BG17951A3 (en) |
CH (6) | CH548366A (en) |
CS (6) | CS170537B2 (en) |
DE (1) | DE1939809B2 (en) |
DK (1) | DK139717B (en) |
ES (6) | ES382425A1 (en) |
FI (1) | FI54912C (en) |
FR (1) | FR2068463B1 (en) |
GB (1) | GB1307436A (en) |
HU (1) | HU163185B (en) |
IE (1) | IE34634B1 (en) |
IL (1) | IL35047A (en) |
NL (1) | NL7011590A (en) |
NO (1) | NO135243C (en) |
PH (1) | PH9520A (en) |
PL (2) | PL93130B1 (en) |
RO (5) | RO57793A (en) |
SE (1) | SE382211B (en) |
SU (3) | SU432712A3 (en) |
YU (2) | YU198170A (en) |
ZA (1) | ZA705411B (en) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50139537A (en) * | 1974-04-25 | 1975-11-07 | ||
US4220603A (en) * | 1977-10-07 | 1980-09-02 | Mitsubishi Chemical Industries, Limited | Pharmaceutically active (omega-aminoalkoxy)bibenzyls |
JPS6045632B2 (en) * | 1978-03-09 | 1985-10-11 | 三菱化学株式会社 | ω-aminoalkoxystilbenes and their acid addition salts |
DE2818765A1 (en) | 1978-04-28 | 1979-11-08 | Basf Ag | AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRENE) -1,3,4-THIADIAZOLE |
DE2818999A1 (en) * | 1978-04-29 | 1979-11-15 | Basf Ag | AMINO DERIVATIVES OF 3-ALKYL-5- (2-HYDROXYSTYRYL) -ISOXAZOLES |
DE2818998A1 (en) * | 1978-04-29 | 1979-11-15 | Basf Ag | 3-ALKYL-5- (2-HYDROXY-STYRYL) -ISOXAZOLES AND METHOD FOR THE PRODUCTION THEREOF |
JPS5629548A (en) * | 1979-08-16 | 1981-03-24 | Mitsubishi Chem Ind Ltd | Omega-aminoalkoxystilbenes and their acid addition salts |
DE2943406A1 (en) | 1979-10-26 | 1981-05-07 | Basf Ag, 6700 Ludwigshafen | AMINO DERIVATIVES OF 2-METHYL-5- (2-HYDROXYSTYRYL) -1,3,4-THIADIAZOL |
DE2943405A1 (en) | 1979-10-26 | 1981-05-07 | Basf Ag, 6700 Ludwigshafen | NEW AMINO DERIVATIVES OF 5- (2-HYDROXYSTYRYL) -ISOXAZOLE |
DE3006809A1 (en) * | 1980-02-23 | 1981-09-24 | Basf Ag, 6700 Ludwigshafen | 2 - ((3-AMINO-2-HYDROXY-PROPOXY) -STYRYL) -ISOXAZOLES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM |
JPS5874379U (en) * | 1981-11-16 | 1983-05-19 | 富士通株式会社 | electronic equipment |
NZ213986A (en) * | 1984-10-30 | 1989-07-27 | Usv Pharma Corp | Heterocyclic or aromatic compounds, and pharmaceutical compositions containing such |
PL3284449T3 (en) | 2011-06-10 | 2020-03-31 | The Procter & Gamble Company | Disposable diapers |
SG195105A1 (en) | 2011-06-10 | 2013-12-30 | Procter & Gamble | Absorbent core for disposable absorbent articles |
MX2013014588A (en) | 2011-06-10 | 2014-01-24 | Procter & Gamble | Absorbent structure for absorbent articles. |
EP2740449B1 (en) | 2012-12-10 | 2019-01-23 | The Procter & Gamble Company | Absorbent article with high absorbent material content |
PL3254656T3 (en) | 2013-06-14 | 2022-01-10 | The Procter & Gamble Company | Absorbent article and absorbent core forming channels when wet |
US9987176B2 (en) | 2013-08-27 | 2018-06-05 | The Procter & Gamble Company | Absorbent articles with channels |
EP2851048B1 (en) | 2013-09-19 | 2018-09-05 | The Procter and Gamble Company | Absorbent cores having material free areas |
PL2886092T3 (en) | 2013-12-19 | 2017-03-31 | The Procter And Gamble Company | Absorbent cores having channel-forming areas and c-wrap seals |
-
0
- BE BE754405D patent/BE754405A/en unknown
-
1969
- 1969-08-05 DE DE1939809A patent/DE1939809B2/en active Granted
-
1970
- 1970-07-21 FI FI2035/70A patent/FI54912C/en active
- 1970-07-22 BG BG17957A patent/BG17951A3/xx unknown
- 1970-07-22 BG BG17958A patent/BG17952A3/xx unknown
- 1970-07-22 RO RO65938A patent/RO57793A/ro unknown
- 1970-07-22 RO RO65937A patent/RO58837A/ro unknown
- 1970-07-22 BG BG15253A patent/BG18599A3/xx unknown
- 1970-07-22 RO RO64019A patent/RO57548A/ro unknown
- 1970-07-22 BG BG17595A patent/BG20095A3/xx unknown
- 1970-07-22 RO RO65939A patent/RO57794A/ro unknown
- 1970-07-22 BG BG17596A patent/BG17950A3/xx unknown
- 1970-07-22 RO RO65491A patent/RO58861A2/en unknown
- 1970-07-22 BG BG17594A patent/BG18600A3/xx unknown
- 1970-07-28 SU SU1701181A patent/SU432712A3/ru active
- 1970-07-28 SU SU1701190A patent/SU450398A3/en active
- 1970-07-28 SU SU1701179A patent/SU428597A3/en active
- 1970-07-30 KR KR7001068A patent/KR780000113B1/en active
- 1970-07-31 CS CS3513*[A patent/CS170537B2/cs unknown
- 1970-07-31 CS CS3514*[A patent/CS170538B2/cs unknown
- 1970-07-31 CS CS3511*[A patent/CS170535B2/cs unknown
- 1970-07-31 CS CS3510*[A patent/CS170534B2/cs unknown
- 1970-07-31 CS CS3512*[A patent/CS170536B2/cs unknown
- 1970-07-31 CS CS5391A patent/CS170533B2/cs unknown
- 1970-08-03 HU HUTO819A patent/HU163185B/hu unknown
- 1970-08-03 JP JP45067958A patent/JPS4941433B1/ja active Pending
- 1970-08-04 ES ES382425A patent/ES382425A1/en not_active Expired
- 1970-08-04 YU YU01981/70A patent/YU198170A/en unknown
- 1970-08-04 ES ES382426A patent/ES382426A1/en not_active Expired
- 1970-08-04 IE IE998/70A patent/IE34634B1/en unknown
- 1970-08-04 CH CH1172670A patent/CH548366A/en not_active IP Right Cessation
- 1970-08-04 IL IL35047A patent/IL35047A/en unknown
- 1970-08-04 CH CH147973A patent/CH548367A/en not_active IP Right Cessation
- 1970-08-04 CH CH148273A patent/CH548983A/en not_active IP Right Cessation
- 1970-08-04 ES ES382430A patent/ES382430A1/en not_active Expired
- 1970-08-04 DK DK401270AA patent/DK139717B/en unknown
- 1970-08-04 ES ES382428A patent/ES382428A1/en not_active Expired
- 1970-08-04 PL PL1970175377A patent/PL93130B1/pl unknown
- 1970-08-04 CH CH147873A patent/CH548981A/en not_active IP Right Cessation
- 1970-08-04 CH CH148073A patent/CH548368A/en not_active IP Right Cessation
- 1970-08-04 NO NO3005/70A patent/NO135243C/no unknown
- 1970-08-04 CH CH148173A patent/CH548982A/en not_active IP Right Cessation
- 1970-08-04 ES ES382429A patent/ES382429A1/en not_active Expired
- 1970-08-04 GB GB3766370A patent/GB1307436A/en not_active Expired
- 1970-08-04 PL PL1970142516A patent/PL78370B1/pl unknown
- 1970-08-04 PH PH11713*UA patent/PH9520A/en unknown
- 1970-08-04 ES ES382427A patent/ES382427A1/en not_active Expired
- 1970-08-05 AT AT943071A patent/AT302344B/en not_active IP Right Cessation
- 1970-08-05 NL NL7011590A patent/NL7011590A/xx not_active Application Discontinuation
- 1970-08-05 ZA ZA705411A patent/ZA705411B/en unknown
- 1970-08-05 SE SE7010773A patent/SE382211B/en unknown
- 1970-08-05 AT AT943371A patent/AT302346B/en not_active IP Right Cessation
- 1970-08-05 AT AT713970A patent/AT301565B/en not_active IP Right Cessation
- 1970-08-05 AT AT943171A patent/AT302345B/en not_active IP Right Cessation
- 1970-08-05 AT AT943271A patent/AT303055B/en not_active IP Right Cessation
- 1970-08-05 FR FR7028941A patent/FR2068463B1/fr not_active Expired
-
1973
- 1973-11-29 JP JP48133937A patent/JPS5113146B1/ja active Pending
- 1973-11-29 JP JP48133940A patent/JPS5113149B1/ja active Pending
- 1973-11-29 JP JP48133939A patent/JPS5113148B1/ja active Pending
- 1973-11-29 JP JP48133941A patent/JPS5113150B1/ja active Pending
- 1973-11-29 JP JP48133938A patent/JPS5113147B1/ja active Pending
-
1978
- 1978-02-17 YU YU00374/78A patent/YU37478A/en unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO135243B (en) | ||
US2703324A (en) | Basic ethers of aralkyl phenols and salts thereof | |
NO145657B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE ALKENDER DERIVATIVES. | |
NO141487B (en) | WIRELESS INFORMATION TRANSMISSION SYSTEM | |
NO162965B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ALFA- (2-OXO-2,4,5,6,7,7A-HEXSAHYDROTIENO- (3,2-C) -5-PYRIDYL) -PHENYL-ACETIC ACID DERIVATIVES. | |
NO792020L (en) | PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE PHENYL PIPERAZINES | |
US3940386A (en) | Substituted cinnamoyl-piperazine-pyridyl compound | |
MX2012005189A (en) | Ire-1 î± inhibitors. | |
DK150196B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 0- (3-AMINO-2-HYDROXYPROPYL) AMIDOXIME DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE SALTS THEREOF | |
WO2013075645A1 (en) | 6-substituted phenyl quinazolone compound and use thereof | |
NO137965B (en) | ANALOGICAL PROCEDURES FOR THE PREPARATION OF NEW CYCLIC THERAPEUTIC ACTIVE DIRECTIVE DERIVATIVES AND SALTS OF THESE WITH PHARMACEUTICAL ACCEPTABLE ACIDS | |
DK149947B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF 1,5-DIPHENYLPYRAZOLINE-3-ON COMPOUNDS OR ACID ADDITION SALTS. | |
US2679501A (en) | Amino derivatives of 2-substituted-4-tert. butylphenol ethers | |
JPS61129172A (en) | Heterocyclic herbicide | |
CA2001182A1 (en) | Pyridylketoxime ether compound and pharmaceutical composition containing it | |
FI62062B (en) | REFERENCE FOR THERAPEUTIC USE OF THERAPEUTIC ANALYSIS 3, -DICHLOROPHENONE-0- (2-AMINOETHYL) -OXIMER | |
CA2071497A1 (en) | 2-substituted 4,5-diphenyl-imidazoles | |
CA2071398A1 (en) | Aminomethyl-substituted 2,3-dihydropyrano/2,3-b/pyridines, process for their preparation and their use in medicaments | |
NO158184B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC EFFECTIVE 1-PHENYLINDAZOL-3-ON COMPOUNDS AND THEIR SALTS. | |
DK159850B (en) | ANALOGY PROCEDURE FOR THE PREPARATION OF PHENYLOIC ACETIC ACID DERIVATIVES | |
US2769808A (en) | Dioxolane compounds | |
NO133708B (en) | ||
Heyes et al. | 74. An investigation of the reactions of phenyl-lithium with some methylpyrimidines | |
NO149209B (en) | ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1- (3- (3,4,5-TRIMETOXYPHENOXY) -2-HYDROXYPROPYL) - 4-ARYL-PIPERAZINE DERIVATIVES | |
DK150602B (en) | METHOD OF ANALOGUE FOR THE PREPARATION OF AMINO DERIVATIVES OF 3-ALKYL-5- (2-HYDROXY-STYRYL) -ISOXAZOLES OR PHYSIOLOGICALLY ACCEPTABLE ACID ADDITION SALTS |